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Abstract
Toxoplasma gondii is an intracellular protozoan parasite that actively invades host cells. During toxoplasmosis,
dendritic cells (DCs) promote CD4+ and CD8+ T cell responses, which are critical for long-term immunity.
Despite this critical role of DCs, questions remain regarding how this population is regulated during infection,
and the specific types of interactions (phagocytosis or active invasion) between parasites and DCs that are
necessary to induce T cell responses.
Previous studies have observed an infection-induced expansion of DC populations during toxoplasmosis, but
the factors that regulate this expansion are currently unknown. Mice deficient in the cytokine Flt3L, which
promotes the proliferation and differentiation of DCs and their precursors, were therefore infected with T.
gondii to determine the role of this cytokine during infection. Flt3L KO mice (which have decreased numbers
of DCs) were acutely susceptible to toxoplasmosis, associated with uncontrolled parasite growth, decreased
production of the critical cytokines IL-12 and Interferon-gamma, and impaired natural killer cell responses.
Infection of these mice induced an expansion of DCs and induced CD4+ and CD8+ T cell proliferation,
however these T cells displayed impaired functionality. Administration of exogenous IL-12 prevented acute
susceptibility in Flt3L KO mice, thus demonstrating that Flt3L-independent mechanisms contribute to T cell
priming and DC expansion during toxoplasmosis, while also highlighting the critical role of DCs as sources of
IL-12.
To determine what types of interactions between DCs and parasites lead to T cell responses, a non-replicating
strain of T. gondii was utilized in combination with a novel approach to track parasite fate in vivo that could
distinguish active invasion from phagocytosis, thus enabling the functional and phenotypic properties of
infected DCs to be compared with those that had phagocytosed parasites, while controlling for parasite
burden. These studies revealed infected DCs to display an activated phenotype unique from DCs that
phagocytosed parasites, and to be potent inducers of T cell responses. Furthermore, pharmacological
inhibition of invasion abrogated T cell responses, thus demonstrating a critical role for actively infected host
cells in inducing adaptive immunity.
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ABSTRACT  
 
ROLES OF DENDRITIC CELLS IN IMMUNITY TO TOXOPLASMA GONDII 
Christopher D. Dupont 
Christopher A. Hunter 
 
Toxoplasma gondii is an intracellular protozoan parasite that actively invades host cells. During 
toxoplasmosis, dendritic cells (DCs) promote CD4+ and CD8+ T cell responses, which are critical 
for long-term immunity. Despite this critical role of DCs, questions remain regarding how this 
population is regulated during infection, and the specific types of interactions (phagocytosis or 
active invasion) between parasites and DCs that are necessary to induce T cell responses.   
Previous studies have observed an infection-induced expansion of DC populations during 
toxoplasmosis, but the factors that regulate this expansion are currently unknown. Mice deficient 
in the cytokine Flt3L, which promotes the proliferation and differentiation of DCs and their 
precursors, were therefore infected with T. gondii to determine the role of this cytokine during 
infection. Flt3L KO mice (which have decreased numbers of DCs) were acutely susceptible to 
toxoplasmosis, associated with uncontrolled parasite growth, decreased production of the critical 
cytokines IL-12 and Interferon-gamma, and impaired natural killer cell responses. Infection of 
these mice induced an expansion of DCs and induced CD4+ and CD8+ T cell proliferation, 
however these T cells displayed impaired functionality. Administration of exogenous IL-12 
prevented acute susceptibility in Flt3L KO mice, thus demonstrating that Flt3L-independent 
mechanisms contribute to T cell priming and DC expansion during toxoplasmosis, while also 
highlighting the critical role of DCs as sources of IL-12. 
To determine what types of interactions between DCs and parasites lead to T cell responses, a 
non-replicating strain of T. gondii was utilized in combination with a novel approach to track 
parasite fate in vivo that could distinguish active invasion from phagocytosis, thus enabling the 
functional and phenotypic properties of infected DCs to be compared with those that had 
phagocytosed parasites, while controlling for parasite burden. These studies revealed infected 
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DCs to display an activated phenotype unique from DCs that phagocytosed parasites, and to be 
potent inducers of T cell responses. Furthermore, pharmacological inhibition of invasion 
abrogated T cell responses, thus demonstrating a critical role for actively infected host cells in 
inducing adaptive immunity. 
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CHAPTER 1:  A REVIEW OF RELEVANT LITERATURE 
 
Introduction 
Background information on toxoplasmosis and its medical significance 
Toxoplasma gondii is an obligate intracellular protozoan parasite that can infect any warm-
blooded vertebrate, and is a pathogen of medical and veterinary significance (Dubey, 2008).  
Infection with T. gondii can be acquired through congenital infection (Wolf et al., 1939), or through 
carnivory, if tissue cysts present in the chronically infected host are ingested (Desmonts et al., 
1965; Kean et al., 1969).  Additionally, it can be acquired through the ingestion of food and water 
contaminated with parasites in the form of oocysts, which are shed in the feces of infected cats 
(Frenkel et al., 1970).  Following ingestion, the parasite converts to a fast-replicating form known 
as the tachyzoite, which results in systemic dissemination of the parasite to all tissues.  Under 
normal circumstances this systemic infection is effectively controlled by the host immune 
response (Johnson, 1992; Weiss and Dubey, 2009).  The parasite then converts to a slow 
replicating form known as the bradyzoite, which persist in tissue cysts in the host neural and 
muscle tissues for the lifetime of the host (Frenkel, 1973).  
 The course of infection in humans can range from asymptomatic to severe, depending on 
the parasite strain and the immune status of the host.  The majority of cases of human infection 
are regarded as asymptomatic and infection rates in some areas are as high as 70% (Pappas et 
al., 2009).  In contrast, congenital infection can result in a number of birth defects, including 
hydrocephalus, chorioretinitis, intracerebral calcifications, or spontaneous abortion (Havelaar et 
al., 2007).  Toxoplasmosis can also cause severe disease in patients with primary or acquired 
deficiencies in T cell function, such as those present in patients with AIDS, Hyper IgM Syndrome, 
those receiving treatment for cancer, and transplant patients being treated with 
immunosuppressive drugs (Derouin and Pelloux, 2008; Israelski and Remington, 1988, 1993; 
Leiva et al., 1998; Tsuge et al., 1998; Yong et al., 2008).  Although such instances are relatively 
rare, symptomatic disease in immunocompetent individuals can result from infection with highly 
virulent strains of T. gondii and can cause severe ocular disease or death (Demar et al., 2007; 
Grigg et al., 2001).  In addition to its direct significance to public health, the genetic malleability of 
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the parasite and its natural ability to infect laboratory animals, have made it an ideal model to 
study parasite genetics and host-pathogen interactions (Dzierszinski and Hunter, 2008). 
 
Invasion process and intracellular niche 
The mechanisms by which T. gondii invades host cells and forms an intracellular niche have been 
extensively reviewed elsewhere (Sibley, 2011), however several aspects of this process are 
directly relevant to this thesis.  T. gondii invades host cells through an active process, using it 
own motor machinery to penetrate the host cell, and phagocytosis of T. gondii parasites leads to 
the killing of the parasite (Sibley, 2011).  During invasion, three successive waves of proteins are 
secreted from parasite organelles, called the micronemes, dense granules, and rhoptries, into the 
host cell.  These proteins can alter host cell function and inhibit the immune response directed 
towards the parasite (Lim et al., 2012).  They also serve to modify the lipid membrane 
surrounding the parasite, forming a specialized intracellular organelle called the parasitophorous 
vacuole (PV).  The PV allows for the transport of essential nutrients from the host cell to the 
parasite, while preventing lysosomal fusion, which would lead to the killing of the parasite 
(Cesbron-Delauw et al., 2008).  The sequestered nature of the parasite within the PV raises 
several fundamental questions regarding the mechanisms by which the parasite interacts with the 
immune system.  For example, can host cells sense the invading parasite, and how would 
infected cells access parasite antigens for presentation to T cells as is required for the effective 
control of the parasite.   
 
Parasite virulence 
As is the case for many pathogens, the outcome of infection with T. gondii is highly dependent on 
the interplay of host and microbial factors.  Genotypic studies have identified three lineages of T. 
gondii into which most strains found in North America and Western Europe can be broadly 
classified (Howe and Sibley, 1995).  In mouse models, parasites belonging to the Type I lineage 
are highly virulent whereas the Type II and Type III lineages are considered avirulent (Howe and 
Sibley, 1995; Sibley and Boothroyd, 1992).  These differences are also reflected in human 
!
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disease, as ocular toxoplasmosis in humans is associated with Type I, but not Type II or Type III 
strains (Grigg et al., 2001).  Given the lethality of Type I strains during murine infection, the vast 
majority of insights into the mechanisms by which the host immune response controls infection 
have been gained through studies using avirulent isolates.  However, the use of reverse genetics 
to compare parasite strains that differ in virulence has allowed the identification of secreted T. 
gondii kinases that modify host cell function. Understanding how these parasite enzymes impact 
host anti-microbial mechanisms provides one approach to define the events that determine the 
outcome of infection (Weilhammer and Rasley, 2011).     
 
Innate immune responses to T. gondii 
Following challenge with T. gondii, monocytes, neutrophils and dendritic cells (DCs) are recruited 
to the site of infection, and all of these cell types have been implicated in resistance to this 
organism (Bliss et al., 2000; Del Rio et al., 2001; Dunay et al., 2008; Dunay et al., 2010; Liu et al., 
2006; Mordue and Sibley, 2003; Tait et al., 2010).  However, questions remain about their 
specific roles in controlling infection.  One of the most critical functions of the innate immune 
response to T. gondii is the ability to sense the pathogen and produce the cytokine IL-12, which 
stimulates natural killer (NK) cells and T cells to produce the cytokine Interferon-gamma (IFN-!) 
(Gazzinelli et al., 1993b; Gazzinelli et al., 1994; Hunter et al., 1994) (Figure 1.1).  IFN-! is the 
major mediator of resistance to T. gondii and promotes multiple intracellular mechanisms to kill 
the parasite and inhibit its replication (Table 1.1).  This Th1 immune response, defined by the 
production of IL-12 and IFN-!, is characteristic of infection with many intracellular pathogens, and 
as is the case for infection with other intracellular pathogens, mice deficient in either IL-12 or IFN-
! that are infected with T. gondii succumb to acute disease and demonstrate an inability to control 
parasite burden (Gazzinelli et al., 1994; Suzuki et al., 1988).   
 The innate production of IL-12 during toxoplasmosis requires that the parasite first be 
sensed by the host. Innate immune receptors called Toll Like Receptors (TLRs) appear to have a 
role in this process.  Thus, mice deficient in the adapter molecule MyD88, which is required for 
downstream signaling from most TLRs, are acutely susceptible to toxoplasmosis (Scanga et al., 
!
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2002).  Specific TLRs implicated in the immune response to T. gondii include TLRs 2, 4, 9, 11 
and 12.  TLRs 11 and 12 respond to a profilin-like molecule conserved among protozoan 
parasites (Jenkins et al., 2010; Koblansky et al., 2013; Yarovinsky et al., 2005) whereas TLRs 2 
and 4 appear to recognize glycosylphosphatidylinositols on the surface of the parasite (Debierre-
Grockiego et al., 2007).  Additionally, following oral infection with T. gondii, bacterial antigens 
translocate from the gut, and TLRs 2, 4, and 9 respond to these microbial insults, thus 
contributing to the development of the Th1 immune response (Benson et al., 2009).  Although 
only deficiency in TLR12 results in acute susceptibility to T. gondii (Koblansky et al., 2013), the 
relative contribution of other TLRs is illustrated by the increased cyst burden present in infected 
mice deficient in one or more of these receptors (Debierre-Grockiego et al., 2007; Yarovinsky et 
al., 2005).  Despite the critical importance of MyD88, other mechanisms of sensing the parasite 
likely exist, as protective immunity can be induced in MyD88-deficient mice using a vaccine strain 
of the parasite, and IL-12 responses are not completely abolished in the absence of MyD88 
(Scanga et al., 2002; Sukhumavasi et al., 2008).        
 Numerous studies have aimed to define the primary cell types responsible for production 
of IL-12 in vivo and have identified neutrophils, inflammatory monocytes, macrophages and DCs 
as relevant sources (Bliss et al., 2000; Bliss et al., 1999a; Gazzinelli et al., 1996a; Mordue and 
Sibley, 2003; Scanga et al., 2002; Whitmarsh et al., 2011).  The relative contribution of DCs to the 
production of IL-12 during toxoplasmosis has been examined using two mouse models: one in 
which DCs can be selectively depleted, and another in which DCs specifically lack expression of 
MyD88 (Hou et al., 2011; Liu et al., 2006).  In both cases, altered function or numbers of DCs 
resulted in lower systemic levels of IL-12 and increased susceptibility to T. gondii.  In these 
models, resistance can be restored by treatment with IL-12 or the transfer of wild type DCs, 
suggesting that DCs are an essential source of IL-12 during toxoplasmosis.  Other studies have 
aimed to define which subsets of DCs are the most relevant sources of IL-12.  Following the in 
vivo administration of soluble T. gondii antigens, the CD8"+ subset of DCs produces IL-12 (Reis e 
Sousa et al., 1997).  More recently, mice lacking the transcription factor Batf3, which have a 
deficiency in CD8"+ DCs, have been shown to succumb to T. gondii associated with a severe IL-
!
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12 defect, reduced CD8+ T cell responses, and high parasite burdens (Mashayekhi et al., 2011).  
The finding that exogenous IL-12 restores survival of Batf3 KO mice is consistent with a model in 
which CD8"+ DCs are an essential source of IL-12. Further evidence for a role for DCs during 
toxoplasmosis comes from the observations that infection with T. gondii induces increased 
numbers of DCs at the site of infection, in the spleen, and in lymph nodes (Tait et al., 2010)!
(Mashayekhi et al., 2011). Currently, the mechanisms that regulate this DC expansion are 
unclear, and they will be explored in Chapter 2 of this thesis.  
 Neutrophils are another source of IL-12 during toxoplasmosis, as they contain pre-stored 
IL-12 and can secrete this cytokine in vitro and in vivo in response to T. gondii (Bliss et al., 2000; 
Bliss et al., 1999a; Bliss et al., 1999b).  Additionally, there are reports that neutrophil depletion 
results in decreased levels of IL-12 and increased parasite replication (Bliss et al., 2001).  These 
findings are complicated by the realization that the strategy used to deplete neutrophils also 
affects other cell types, including inflammatory monocytes (Dunay et al., 2010).  Regardless, mice 
deficient in the chemokine receptor CXCR2, which is essential for neutrophil recruitment to the 
site of infection, have higher parasite levels in the central nervous system (CNS), suggesting a 
role for neutrophils during toxoplasmosis (Del Rio et al., 2001).  Neutrophils are also implicated in 
other effector mechanisms that directly kill parasites, including phagocytosis, the release of 
reactive chemical species, and the formation of extracellular traps (Abi Abdallah et al., 2012; 
Chtanova et al., 2008; Konishi and Nakao, 1992; Nakao and Konishi, 1991).  While phagocytosis 
of T. gondii by neutrophils has been observed in vitro (Konishi and Nakao, 1992; Nakao and 
Konishi, 1991), several groups have reported that p47phox, an enzyme component necessary for 
the oxidative burst generated by neutrophils following phagocytosis, is unnecessary for resistance 
to T. gondii (Alexander et al., 1997; Egan et al., 2008).  Indeed, in vivo imaging studies have 
observed swarms of neutrophils that congregate around infected cells, but the parasites present 
in the neutrophils appear to be largely intact (Chtanova et al., 2008). However, infection with T. 
gondii does induce increased extracellular DNA at the site of infection, which is dependent upon 
the presence of neutrophils, and this may be explained by the release of DNA from neutrophils to 
form extracellular traps (Abi Abdallah et al., 2012).  In vitro studies suggest that the formation of 
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these traps results in decreased parasite vitality and may contribute to the control of T. gondii in 
vivo.      
 Monocytes are also required for resistance during toxoplasmosis, as mice deficient in the 
chemokine receptor CCR2, which is necessary for monocyte recruitment to the site of infection, 
exhibit increased susceptibility when challenged (Benevides et al., 2008; Dunay et al., 2010; 
Robben et al., 2005). Inflammatory monocytes produce IL-12 in vitro and in vivo when stimulated 
with T. gondii, however it is not clear whether they are a critical source of this cytokine (Aldebert 
et al., 2007; Benevides et al., 2008; Dunay et al., 2010; Goldszmid et al., 2012; Mordue and 
Sibley, 2003; Robben et al., 2005; Whitmarsh et al., 2011).  It has also been proposed that these 
populations contribute to the direct control of T. gondii through the generation of nitric oxide (NO), 
which inhibits parasite replication (Dunay and Sibley, 2010).  In support of this model, 
inflammatory monocytes express inducible nitric oxide synthase (iNOS), the enzyme responsible 
for catalyzing the production of NO, and inflammatory monocytes are able to kill and inhibit the 
replication of T. gondii in vitro (Borges and Johnson, 1975; Mordue and Sibley, 2003; Wilson and 
Remington, 1979).  Additionally, CCR2 KO mice given a low dose oral challenge of T. gondii 
succumb approximately 3-4 weeks after infection, and this is associated with decreased 
expression of iNOS and increased parasite burdens in the CNS (Benevides et al., 2008).  
Although monocytes are clearly critical for survival during toxoplasmosis, their role is not limited 
to production of nitric oxide, as iNOS-deficient mice survive acute challenge, while deficiencies in 
monocyte recruitment can lead to acute susceptibility (Dunay et al., 2010; Robben et al., 2005; 
Scharton-Kersten et al., 1997).  Monocytes also produce IL-1 in response to soluble toxoplasma 
antigens (Gazzinelli et al., 1995), and this factor can enhance anti-toxoplasmic effector 
mechanisms in macrophages and astrocytes in vitro (Halonen et al., 1998; Hammouda et al., 
1995b).  Moreover, IL-1 can synergize with IL-12 to promote production of IFN-! from innate and 
adaptive sources (Hunter et al., 1995; Shibuya et al., 1998).  It is also possible that monocytes 
proceed to develop into DCs that are capable of inducing adaptive immune responses 
(Goldszmid et al., 2012) (Dominguez and Ardavin, 2010), or macrophages that can control 
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infection through immune GTPase-mediated mechanisms, as will be discussed later in this 
article.   
 Natural killer (NK) cells are another innate population involved in immunity to T. gondii, 
and in mice that lack T cells they provide a limited mechanism of resistance through their ability to 
produce IFN-! (Denkers et al., 1993; Hunter et al., 1994; Johnson et al., 1993; Sher et al., 1993).  
NK cell activity peaks early during infection, and although their activity is elevated during chronic 
toxoplasmosis, they do not appear to be significant contributors to immunity during the chronic 
stage of infection (Denkers et al., 1993; Hauser et al., 1982; Hunter et al., 1994; Johnson et al., 
1993; Kang and Suzuki, 2001; Sher et al., 1993).  Consequently, most studies have focused on 
the early events that control NK cell activity, leading to a model in which IL-12 produced by other 
innate cells (e.g. neutrophils, monocytes and DCs) promotes NK cell-mediated production of IFN-
! (Gazzinelli et al., 1993b; Hunter et al., 1994).  In addition to IFN-!, NK cells produce the 
cytokine IL-10, the significance of which will be discussed in a later section of this chapter 
(Perona-Wright et al., 2009).  Human and murine NK cells can also be cytotoxic for cells infected 
with T. gondii (Hauser and Tsai, 1986; Subauste et al., 1992), but it has been proposed that NK 
cells become infected with the parasite following the lysis of infected cells, which may promote 
the dissemination of the parasite (Persson et al., 2009).  
 NK cells can also act to promote adaptive immune responses.  Thus, in the absence of 
CD4+ T cells, they can provide help to the CD8+ T cell response (Combe et al., 2005).  One 
mechanism by which this help is accomplished is by increasing IL-12 production from DCs 
through interactions dependent on the molecule NKG2D (Guan et al., 2007).  Additionally, 
production of IFN-! by NK cells has been implicated in the development of optimal CD4+ T cell 
responses (Goldszmid et al., 2007).  
 
Adaptive Immune Responses to T. gondii 
The importance of adaptive immune responses for resistance to T. gondii during human infection 
is demonstrated by the increased susceptibility of patients with primary or acquired defects in T 
cell function, and mice with deficiencies in B cells, CD4+ T cells or CD8+ T cells survive the acute 
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stage of infection, but ultimately show increased susceptibility to T. gondii (Denkers et al., 1997; 
Johnson and Sayles, 2002; Kang et al., 2000).  Understanding how these different cell 
populations are integrated to provide long-term resistance has been challenging, but several 
advances in technology have improved our ability to study adaptive immune responses to T. 
gondii.  For example, the identification of the molecular epitopes of T. gondii recognized by CD8+ 
T cells has allowed the measurement of antigen-specific CD8+ T cell responses during infection, 
and provided insight into the mechanisms by which antigen is presented (Blanchard et al., 2008)!
(Wilson et al., 2010).  This has been complemented by the development of parasites that express 
model antigens such as ovalbumin, #-galactosidase, and E"RFP, as well as the use of two-
photon imaging to allow visualization of immune cells following infection (Pepper et al., 2004) 
(Pepper et al., 2008) (Dzierszinski and Hunter, 2008; John et al., 2010).  These advances are 
currently allowing a higher resolution analysis of the events that mediate the control of T. gondii, 
and enabled many of the experiments performed in this thesis. 
 
CD4+ T cell responses:  Initiation and mechanisms of controlling infection   
 As mentioned earlier, CD4+ T cells are critical for resistance during toxoplasmosis, as the 
emergence of severe toxoplasmosis is concomitant with the decline in T cell numbers in patients 
infected with HIV (Israelski and Remington, 1988; Luft et al., 1984).  Similarly, in mouse models, 
the lack of CD4+ T cells is associated with increased susceptibility during the chronic stage of 
infection (Johnson and Sayles, 2002).  CD4+ T cells provide several critical regulatory functions in 
mediating resistance to toxoplasmosis.  During the early stages of infection they contribute to 
optimal B and CD8+ T cell responses (discussed in subsequent sections of this chapter) (Glatman 
Zaretsky et al., 2012; Johnson and Sayles, 2002; Lutjen et al., 2006), and the ability of these cells 
to control chronic infection may be attributed to their production of cytokines such as IFN-!, or 
their expression of CD40L (also referred to as CD154), which can activate effector mechanisms 
in macrophages and other innate cells expressing CD40 on their surface (Andrade et al., 2005; 
Gazzinelli et al., 1992a; Portillo et al., 2010; Reichmann et al., 2000; Subauste et al., 2007; 
Subauste and Wessendarp, 2006). 
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 The initiation of T cell responses requires that naïve CD4+ or CD8+ T cells encounter 
antigen presenting cells bearing their cognate antigen in the context of MHCII or MHCI molecules 
respectively, in conjunction with co-stimulatory and cytokine signals needed for T cell activation 
(Curtsinger et al., 2003; Curtsinger et al., 1999; Guermonprez et al., 2002; Harding et al., 1992).  
During toxoplasmosis, ligation of the molecules CD28 and ICOS, expressed on the surface of T 
cells, contributes to the co-stimulatory signals, while IL-12 provides the cytokine signal required to 
promote proliferation and differentiation into populations that produce IFN-! (Gazzinelli et al., 
1994; Villegas et al., 2002; Wilson et al., 2008).    
 B cells, macrophages, and DCs are all capable of presenting antigen to CD4+ T cells, 
though DCs are generally considered the most crucial antigen presenting cell population in vivo 
(Jenkins et al., 2001).  Following infection with T. gondii, multiple populations of DCs undergo 
expansion and acquire an activated phenotype.  Additionally, challenge of mice with parasites 
engineered to express the model antigen E"RFP revealed that CD8"+ and plasmacytoid DCs 
(pDCs) express complexes of MHC class II and E", a peptide derived from E"RFP, on their 
surfaces (Pepper et al., 2008).  While these studies implicate pDCs and CD8"+ DCs as 
responsible for presenting antigen to CD4+ T cells during toxoplasmosis, the use of mice with 
deficiencies in specific DC compartments, as well as mouse models that allow for the selective 
depletion of DCs or DC subsets, may be useful to further define the roles of these populations in 
antigen presentation (Jung et al., 2002; Mashayekhi et al., 2011; Takagi et al., 2011).   
 The mechanisms by which professional antigen presenting cells acquire parasite 
antigens for presentation in the context of MHCII are unclear, and there are several possible 
models to explain how this may be accomplished (Figure 1.2).  Since there are multiple reports 
that murine DCs and monocytes infected with T. gondii express low levels of MHCII and co-
stimulatory molecules, it has been suggested that infected cells would be poor presenters of 
antigen (Goldszmid and Sher, 2010; Lang et al., 2006; McKee et al., 2004). Thus, antigen 
acquisition might occur through the phagocytosis of parasites, infected cells, or parasitic debris, 
or through the endocytosis of antigens secreted by the parasite (Figure 1.2a).  In vitro studies 
have demonstrated that murine DCs are able to present antigen derived from live and heat-killed 
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parasites to CD4+ T cells (Goldszmid et al., 2009).  Because heat-killed parasites cannot invade 
cells, these data are consistent with a model in which antigen is acquired via the phagocytosis of 
parasites.  
 Alternatively, antigen may be acquired by antigen presenting cells through active invasion 
mediated by the parasite, or through abortive invasion events in which antigens are injected into 
cells that are not subsequently infected (Figure 1.2b) (Koshy et al., 2010).  This model is 
supported by experiments conducted using human monocytes and DCs, in which cells exposed 
to viable parasites upregulated MHCII and co-stimulatory molecules, whereas cells exposed to 
heat-killed parasites did not (Subauste et al., 1998; Subauste and Wessendarp, 2000).  
Additionally, these studies found that exposure to live parasites was necessary for the ability to 
present antigen.  These findings are not entirely consistent with the reports above (Goldszmid et 
al., 2009; McKee et al., 2004), although this may be attributable to differences between human 
and murine cells.  It is also relevant to note that results obtained from in vitro studies may not be 
representative of what occurs in vivo. Currently, in vivo studies examining the mechanisms by 
which antigen is presented to CD4+ T cells during toxoplasmosis are lacking.  These issues will 
be further explored in Chapter 3 of this thesis, in which an in vivo approach is utilized to 
phenotypically compare the cells that have phagocytosed T. gondii to those that are actively 
invaded. Additionally, pharmacological inhibition of invasion, and the selective transfer of dendritic 
cells infected with a replication-deficient strain of T. gondii will be utilized to determine which of 
these populations are critical for the induction of adaptive immune responses.  
 
Humoral immunity is essential for resistance to toxoplasmosis 
It has long been recognized that infection with T. gondii promotes antibody responses, and that 
these antibodies can kill the parasite (Sabin and Feldman, 1948).  Indeed, parasite-specific IgM, 
IgA, IgE and IgG2 antibodies have been isolated from human patients, and detection of parasite 
specific antibodies is an effective diagnostic tool to distinguish newly infected individuals from 
those in the chronic stage of infection (Correa et al., 2007; Remington, 1969; Remington et al., 
1968; Remington et al., 2004; Sabin and Feldman, 1948). The critical role of antibody in immunity 
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to T. gondii is demonstrated by the phenotype of µMT mice, which are deficient in B cells.  These 
mice develop apparently normal IFN-! responses, but succumb to infection within 3-4 weeks 
following challenge, associated with high parasite burdens in the CNS (Kang et al., 2000).  This 
increase in susceptibility is likely due to a lack of antibodies, as the passive transfer of antibodies 
confers protection to B cell-deficient mice (Johnson and Sayles, 2002). Antibodies can mediate 
their protective effects through a variety of mechanisms.  In vitro studies have found that they can 
opsonize parasites for phagocytosis, block invasion, and also activate the classical complement 
pathway (Erbe et al., 1991; Hammouda et al., 1995a; Nakao and Konishi, 1991; Schreiber and 
Feldman, 1980; Suzuki and Tsunematsu, 1971; Vercammen et al., 1999).  The in vivo relevance 
of complement activation is illustrated by studies in which treatment of mice with an antibody that 
binds to the complement protein C3 results in acute susceptibility to toxoplasmosis (Johnson et 
al., 1996).  Additional studies are required to define the contribution of other antibody-mediated 
functions.   
 As mentioned previously, CD4+ T cells are necessary to promote optimal B cell 
responses and mice deficient in or depleted of CD4+ T cells display lower parasite-specific 
antibody titers (Glatman Zaretsky et al., 2012; Johnson and Sayles, 2002).  Furthermore, the 
increased susceptibility of CD4+ T cell-deficient mice can be ameliorated by the passive transfer 
of antibodies, indicating that the defect in antibody responses likely contributes to the failure to 
control parasite numbers (Johnson and Sayles, 2002).  Curiously, infection with T. gondii results 
in severe disruption of splenic architecture and the loss of distinct B cell zones (John et al., 2009)!
(Glatman Zaretsky et al., 2012).  Since B cell zones are considered the main location where CD4+ 
T cells provide help to B cells (Vinuesa et al., 2005), this raises the question of whether there is a 
specialized microenvironment where T-B interactions occur when B cell zones are absent.  Since 
disruption of secondary lymphoid structures is characteristic of many infections (Benedict et al., 
2006; Cadman et al., 2008; Odermatt et al., 1991; Racine et al., 2010; Scandella et al., 2008; St 
John and Abraham, 2009), murine models of toxoplasmosis may prove a useful system to 
interrogate the mechanisms by which CD4+ T cells help B cell responses, and the extent to which 
splenic architecture contributes to such interactions.   
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CD8+ T cell response: Initiation and control of parasite burden 
Given that T. gondii is an intracellular pathogen, it is not surprising that CD8+ T cells, which are 
specialized to recognize and destroy cells infected with viral, bacterial and parasitic organisms, 
also have a critical role in mediating resistance to this infection. CD8+ T cells can control infection 
through the production of inflammatory cytokines such as IFN-!, through CD40/CD40L 
interactions, and through the perforin-mediated cytolysis of infected host cells (Denkers et al., 
1997; Gazzinelli et al., 1992a; Reichmann et al., 2000).  Indeed, mice deficient in CD8+ T cells 
show increased susceptibility to toxoplasmosis, succumbing approximately 50 days post-infection 
(Denkers et al., 1997).  Furthermore, the adoptive transfer of CD8+ T cells from chronically 
infected mice, or mice vaccinated with an attenuated strain of T. gondii, is sufficient to confer 
resistance (Gigley et al., 2009; Parker et al., 1991).  Additional evidence comes from in vivo 
depletion studies using chronically infected mice, in which depletion of CD8+ T cells and CD4+ T 
cells results in reactivation of the infection and severe disease, but depletion of CD4+ T cells 
alone had limited impact (Gazzinelli et al., 1992a).   
 As previously described, CD8+ T cell responses are initiated when naïve CD8+ T cells 
encounter their cognate antigen in the context of MHCI on the surface of antigen presenting cells, 
accompanied by co-stimulatory and cytokine signals.  Some of the earliest studies on the CD8+ T 
cell response identified the Surface Antigen 1 (SAG-1) protein as a target of CD8+ T cells, 
although the specific peptide sequence of SAG-1 that the CD8+ T cells recognize remains 
unknown (Khan et al., 1988).  More recently, technical advancements have accelerated the 
discovery of epitopes of T. gondii that are recognized by CD8+ T cells.   Thus, in 2008, two 
studies identified peptides derived from T. gondii that are presented in the context of the H2-Ld 
allele of MHCI.  These include peptides from the dense granule proteins GRA4 and GRA6, and 
the rhoptry protein ROP7 (Blanchard et al., 2008; Frickel et al., 2008).  Of these, the GRA4 and 
ROP7 epitopes are conserved across multiple strains of T. gondii, whereas expression of the 
GRA6 epitope is limited to Type II strains.  Another epitope, derived from the protein Tgd_057, is 
presented in the context of the MHCI allele H2-Kb, and is also conserved among multiple 
genotypic strains (Wilson et al., 2010).  The function of Tgd_057 is unclear, but despite the 
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presence of a secretory signal, it localizes primarily to the cytosol of the parasite.  It is of interest 
that all of these proteins, with the possible exception of Tgd_057, are secreted from the parasite.  
While this observation likely reflects, in part, the methods used to screen for these epitopes, it is 
also in agreement with studies in which parasites are engineered to express model antigens, as 
these studies consistently demonstrate that antigens secreted from T. gondii induce more robust 
T cell responses than antigens expressed in the cytosol (Gregg et al., 2011; Kwok et al., 2003; 
Pepper et al., 2004).  These findings may provide insight into the mechanisms by which antigen is 
presented to T cells, a theme which will be explored in Chapter 3 of this thesis.   
 Currently, there are several questions about the identity of the cell populations involved in 
antigen presentation to CD8+ T cells during toxoplasmosis.  DCs are known to be efficient antigen 
presenting cells, and are crucial for the development of CD8+ T cell responses to T. gondii, 
however there is a lack of studies that clearly distinguish their role as sources of IL-12 from their 
role as presenters of antigen (Liu et al., 2006; Tait et al., 2010).  In vivo imaging studies have 
observed extensive interactions between DCs and antigen-specific CD8+ T cells, suggesting a 
role for DCs in antigen presentation (Chtanova et al., 2009; John et al., 2009).  In contrast, using 
a bone marrow chimera approach to generate mice in which MHCI expression was limited to non-
hematopoietic cells, Dzierszinski et al. demonstrated that challenge of these mice with T. gondii 
resulted in an apparently normal CD8+ T cell response (Dzierszinski et al., 2007).    One 
interpretation of these data is that DCs are not necessary for antigen presentation during 
toxoplasmosis.  Further experimentation is therefore necessary to determine which cell type 
presents antigen to CD8+ T cells. 
 As is the case for antigen presentation to CD4+ T cells, there are multiple pathways by 
which parasite antigens may be acquired for presentation to naïve CD8+ T cells (Figure 1.2).  In 
vitro and ex vivo studies have found that infected DCs are able to present antigen, whereas cells 
exposed to parasites or parasite antigens that were not infected are unable to do so (Dzierszinski 
et al., 2007; Goldszmid et al., 2009; Gubbels et al., 2005).  In contrast, the DCs observed to 
interact with CD8+ T cells in vivo appear to be largely uninfected (Chtanova et al., 2009; John et 
al., 2009), suggesting a possible role for uninfected cells in presenting antigen to naïve CD8+ T 
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cells in vivo, which is consistent with numerous reports of cross-presentation in other models of 
infection (Lin et al., 2008).   
 While the cellular pathways by which phagocytosed antigens are processed and 
eventually presented in the context of MHCI have been widely studied in a variety of systems (Lin 
et al., 2008), it is less clear how a cell infected with T. gondii can present antigen, given that the 
parasite resides in a specialized non-fusogenic vacuole.  Several studies using reporter systems 
in which host cells respond to antigens derived from T. gondii have demonstrated that secreted 
antigens can enter the cytoplasm of infected cells (Gubbels et al., 2005; Koshy et al., 2010).  
These antigens would then be transported from the cytosol into the endoplasmic reticulum by the 
Transporter Associated with Antigen Processing (TAP) (Gubbels et al., 2005).  This model is 
consistent with studies demonstrating that secreted antigens from T. gondii are preferentially 
presented to T cells (Blanchard et al., 2008; Frickel et al., 2008; Gregg et al., 2011; Kwok et al., 
2003; Pepper et al., 2004).  Alternatively, the PV can fuse with the endoplasmic reticulum, 
providing another mechanism by which antigens may escape sequestration and enter the protein 
transport pathway (Goldszmid et al., 2009). The role of infected cells in initiating CD8+ T cell 
responses during toxoplasmosis will be further explored using an in vivo model in Chapter 3 of 
this thesis. 
 CD8+ T cell responses to T. gondii are influenced by help provided by CD4+ T cells 
(Combe et al., 2005; Lutjen et al., 2006).  Although depletion of CD4+ T cells does not affect the 
magnitude of the CD8+ T cell response during the early stage of CD8+ T cell expansion and 
activation, CD4+ T cells are necessary for the maintenance of CD8+ T cell effector functions 
during the chronic stage of infection, and this help must be provided during the acute stage of 
infection (Lutjen et al., 2006).  Further insights regarding the nature of CD4+ T cell help have been 
gained from studies using the attenuated vaccine strains of T. gondii ts-4 and cpsII, both of which 
require CD4+ T cell help for optimal protective CD8+ T cell responses (Denkers et al., 1996; 
Jordan et al., 2009).  In current models, ts-4 vaccination stimulates CD4+ T cells to produce the 
growth factor IL-2, which provides an essential signal for CD8+ T cells.  Indeed, neutralization of 
IL-2 results in diminished CD8+ T cell responses and decreased protection (Denkers et al., 1996).  
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Other potential mechanisms by which CD4+ T cells may provide help include the licensing of 
DCs, or direct interactions with CD8+ T cells through CD40/CD40L interactions (Bevan, 2004).     
 The vast majority of studies examining the CD8+ T cell response have used avirulent 
Type II strains of T. gondii.  Recently, it has become apparent that CD8+ T cell responses are 
dramatically decreased following infection with the highly virulent RH strain of the parasite and 
there are several possible explanations for this phenotype (Tait et al., 2010).  The defective CD8+ 
T cell response may be influenced by the activities of the parasite virulence factor ROP18 which 
(in addition to other functions) binds to the host protein Activating Transcription Factor 6 # 
(ATF6#), leading to its degradation (Yamamoto and Takeda, 2012).  In support of this model, 
ATF6#-deficient mice have a defective CD8+ T cell response when infected with T. gondii, and 
ROP18-deficient parasites from an RH background induce greater production of IFN-! from CD8+ 
T cells, relative to wild type RH parasites.  Decreased CD8+ T cell responses may also result from 
an abbreviated DC response during RH infection, relative to infection with an avirulent Type II 
strain (Jordan et al., 2010).  As the adoptive transfer of large numbers of antigen-specific CD8+ T 
cells is able to transiently reduce parasite burden during RH infection, it seems likely that the 
decreased CD8+ T cell response is a contributing factor to the virulence of the RH strain (Tait et 
al., 2010).  
 More subtle changes in CD8+ T cell responses may also help to explain differences in 
susceptibility among mouse strains.  Whereas the C57B/6 inbred mouse strain succumbs to T. 
gondii during the chronic stage of infection, BALB/c mice are relatively resistant to toxoplasmic 
encephalitis.  This difference in susceptibility has been genetically mapped to the MHC Class I 
H2-Ld allele, implicating CD8+ T cells as being responsible for this difference in susceptibility 
(Brown et al., 1995; Suzuki et al., 1994).  The recent identification of an immunodominant epitope 
from the protein GRA6, recognized by CD8+ cells, that binds to the H2-Ld Allele has led to the 
hypothesis that recognition of this peptide is crucial for controlling T. gondii infection in BALB/c 
mice, and may account for the differences in virulence among mouse strains (Blanchard et al., 
2008).  Because expression of this epitope is restricted to Type II strains of T. gondii, its relative 
significance could be tested by replacing the peptide with the sequence present in Type I or Type 
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III strains.  Alternatively, it may be possible to tolerize mice to this epitope through vaccination, as 
has been reported in other systems (Rosenberg et al., 2010).  Regardless, these studies highlight 
the importance of GRA6 as a target for protective CD8+ T cells.   
 
Effector mechanisms controlling T. gondii infection 
As discussed in the previous section, cellular immunity mediates protection through the 
production of inflammatory cytokines such as IFN-!.  Other molecular signals, such as the 
cytokine tumor necrosis factor alpha (TNF-") and CD40 ligation are also required for resistance 
during chronic toxoplasmosis (Deckert-Schluter et al., 1998; Reichmann et al., 2000; Schluter et 
al., 2003; Yap et al., 1998).  This section describes how these distinct pathways are integrated to 
engage specific effector mechanisms required to directly control infection with T. gondii. 
 
Nitric oxide inhibits replication of T. gondii  
Since the early 1980’s, it was recognized that IFN-! can activate macrophages to kill a variety of 
intracellular organisms, including T. gondii (Nathan et al., 1983), and during the late 1980’s it was 
reported that IFN-! is also essential in vivo for resistance to T. gondii (Suzuki et al., 1988).  These 
findings raised the fundamental question of how this cytokine promotes control of T. gondii and 
other pathogens.  It was proposed that the protective effects of IFN-! may be mediated by 
inducing increased synthesis of Nitric Oxide (NO) (Adams et al., 1990).  Consistent with this 
hypothesis, expression of inducible nitric oxide synthase (iNOS), the enzyme responsible for 
catalyzing the reaction that results in production of NO, is increased in macrophages by 
stimulation with IFN-!, and NO inhibits replication of T. gondii in macrophages and other cell 
types (Chao et al., 1993; Jun et al., 1993; Koide et al., 1993; Langermans et al., 1992; Zhao et 
al., 2009a).  Importantly, IFN-! alone is not typically sufficient to activate macrophages to kill T. 
gondii, and additional signals provided by factors such as TNF-" or CD40L are required for 
optimal iNOS expression (Jana et al., 2001; Langermans et al., 1992).  In vivo evidence for a role 
of NO in controlling toxoplasmosis came from a study in which administration of the iNOS 
inhibitor aminoguanidine to infected mice resulted in increased parasite burdens (Hayashi et al., 
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1996).  Subsequently, iNOS-deficient mice were developed and found to display increased 
susceptibility to toxoplasmosis, succumbing to disease in the chronic stage of infection (Scharton-
Kersten et al., 1997). Although the specific mechanism by which NO inhibits replication of T. 
gondii remains to be determined, studies using intracellular bacterial pathogens have shown that 
NO can inhibit bacterial enzymatic activity and directly damage DNA (Chakravortty and Hensel, 
2003), which would preferentially affect pathogen replication and account for the static effects of 
NO. 
 
IFN-! mediates protection through the p47 GTPases  
The increased susceptibility of iNOS-deficient mice to toxoplasmic encephalitis clearly implicated 
iNOS in immunity to T. gondii, but also pointed toward iNOS-independent mechanisms by which 
IFN-! mediates protection during the acute phase of infection.  Like iNOS, members of the p47 
GTPase family (also referred to as the Immune Related GTPase family (IRGs)) are also 
upregulated in response to IFN-! (Howard et al., 2011; Taylor et al., 1996), but the importance of 
this family was first apparent when mice that lack the p47 GTPase IGTP (Irgm3) were infected 
with T. gondii.  These mice have normal IFN-! responses, but succumb to acute toxoplasmosis 
due to high parasite burdens (Taylor et al., 2000).  Subsequent studies revealed other members 
of this family, including LRG-47 (Irgm1), IRG-47 (Irgd), IIGP1 (Irga6), and TGTP (Irgb6) to be 
involved in immunity to T. gondii as well (Collazo et al., 2001; Fentress et al., 2010; Pawlowski et 
al., 2011; Zhao et al., 2009a).  The specific mechanisms by which individual members of the p47 
GTPase family promote the clearance of T. gondii are the subject of ongoing studies in many 
laboratories (Howard et al., 2011).  There are reports that in IFN-! activated cells p47 GTPases 
colocalize to the PV, which then develops a tight fitting morphology followed by a rough and 
disrupted appearance before being stripped away (Fentress et al., 2010; Hunn et al., 2008; 
Khaminets et al., 2010; Ling et al., 2006; Martens et al., 2005; Steinfeldt et al., 2010; Zhao et al., 
2009a; Zhao et al., 2009b; Zhao et al., 2008).  Once free in the cytosol, the parasite egresses the 
infected cell or becomes permeabilized and killed (Melzer et al., 2008; Zhao et al., 2009a).  In the 
latter studies, the host cell was observed to undergo necrosis after killing the parasite.  
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Additionally, other studies have observed the exposed cytosolic parasite to be disposed of by 
xenophagy, the process by which foreign bodies within a cell are eliminated using the same 
cellular machinery involved in autophagy (Ling et al., 2006).  In further support of a role for 
autophagic machinery in immunity to T. gondii, the autophagy protein Atg5 has been found to be 
necessary for the disruption of the PV and resistance to this infection in vivo (Zhao et al., 2008).  
Additionally, CD40 ligation has been observed to induce xenophagic elimination of parasites 
independently of p47 GTPases, as will be discussed a later section of this chapter (Subauste and 
Wessendarp, 2006). 
 Given the important role of the p47 GTPases in immunity to T. gondii, it is not surprising 
that the parasite has evolved strategies to interfere with their function.   At least three members of 
the p47 GTPase family, Irga6, Irgb6 and Irgb10, are phosphorylated by ROP18, resulting in 
changes in their functionality or cellular localization associated with increased virulence (Fentress 
et al., 2010; Steinfeldt et al., 2010).  Additionally, the recruitment of GBP1, a member of the 
guanylate-binding protein family (GBPs), to the PV is also inhibited by the parasite-derived 
virulence factors GRA15, ROP16 and ROP18 (Virreira Winter et al., 2011), and recent reports 
have demonstrated that this family of enzymes participates in p47 GTPase-mediated killing 
(Selleck et al., 2013; Yamamoto et al., 2012). 
 
The role of tryptophan degradation as a defense mechanism 
IFN-! can also mediate protective effects against T. gondii by promoting tryptophan degradation 
in a variety of infected cell types, including fibroblasts, macrophages, and brain cells (Daubener 
et al., 1996; Daubener et al., 2001; Murray et al., 1989; Pfefferkorn, 1984).  Treatment of cells 
with IFN-! results in the upregulation of the genes indolamine 2,3-dioxygenase 1 and 2 (IDO-1 
and IDO-2), which catalyze the degradation of tryptophan (Metz et al., 2007; Murray et al., 1989).  
Because T. gondii is a natural tryptophan auxotroph, the increased degradation of tryptophan by 
host cells inhibits parasite growth (Sibley et al., 1994).  The in vivo relevance of this pathway is 
illustrated by the finding that long-term treatment of infected mice with inhibitors of IDO-1 and 2 
results in increased susceptibility and increased parasite burdens during chronic infection 
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(Divanovic et al., 2012).  Interpretation of this finding is complicated by the fact that IDO has other 
known immune functions such as suppression of DC and effector T cell functions, as well as 
promotion of regulatory T cell responses (Soliman et al., 2010).  
 
Members of the TNF family are necessary for immunity to T. gondii 
In addition to IFN-!, members of the TNF family such as CD40L, TNF-! and LT-", are also 
required for protection during the chronic stage of infection (Reichmann et al., 2000; Schluter et 
al., 2003; Yap et al., 1998).  The critical role of TNF-" is demonstrated by studies in which 
neutralization of this cytokine results in increased susceptibility and higher parasite burdens 
(Gazzinelli et al., 1993a).  Additionally, mice deficient in TNF-" (TNF-" KO) or the components of 
its receptor (TNFR KO) succumb to infection approximately 3-4 weeks post-challenge despite 
having functional IFN-! responses (Deckert-Schluter et al., 1998; Schluter et al., 2003; Yap et al., 
1998).  TNF-" is produced by a number of cell populations in response to T. gondii or T. gondii 
antigens, including neutrophils (Bennouna et al., 2003; Bliss et al., 1999a), DCs (Bennouna et al., 
2003), macrophages (Li et al., 1994), microglia (Schluter et al., 2001), and T cells (Schluter et al., 
1997).  TNF-" synergizes with IFN-! to promote anti-parasitic mechanisms in macrophages, as 
well as non-hematopoietic cells (Chang et al., 1990; Yap and Sher, 1999).  In vitro studies have 
demonstrated that this can be mediated through the production of nitric oxide (Koide et al., 1993; 
Langermans et al., 1992).  Additionally, TNF-" KO mice, TNFR KO mice, and mice treated with a 
neutralizing antibody for TNF-" display decreased iNOS expression (Deckert-Schluter et al., 
1998; Gazzinelli et al., 1993a; Schluter et al., 2003).  Collectively, these data support a model in 
which TNF-" mediates its protection by inducing expression of iNOS.  However, there are also 
data that suggest that susceptible TNFR KO mice infected with T. gondii can have appropriate 
levels of iNOS, indicating that TNF-" can mediate protection through iNOS-independent 
mechanisms (Yap et al., 1998).  Because TNF-" KO and TNFR KO mice are capable of surviving 
the acute stage of infection, it is clear that TNF-" is not required for the IGTP-mediated 
elimination of the parasite (Deckert-Schluter et al., 1998; Schluter et al., 2003; Yap et al., 1998).  
This notion is also supported by in vitro studies, in which macrophages show no defect in their 
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ability to kill parasites in the absence of TNF-" signaling (Zhao et al., 2007).  However, 
interpretation of these results is complicated by the finding that TNF-" plays a more prominent 
role in activating macrophages when concentrations of IFN-! are limiting (Yap et al., 1998).  
Thus, the chronic susceptibility of mice deficient in TNF-" signaling may result from changes in 
the expression of IFN-! during the course of infection rather than a deficiency in any one specific 
effector mechanism that is absolutely dependent upon TNF-".    
 Another component of the TNF family involved in immunity to T. gondii is CD40L, which 
is expressed on T cells and binds to CD40 expressed on macrophages and other cell populations 
(Subauste, 2009).  The importance of CD40/CD40L interactions to promote immunity to T. gondii 
is evidenced by the increased susceptibility of patients with Hyper-IgM syndrome, a disease 
characterized by defective CD40L expression (Leiva et al., 1998; Tsuge et al., 1998; Yong et al., 
2008).  During human toxoplasmosis, CD40/CD40L interactions are necessary to promote 
optimal production of IFN-! and class switched antibody (Leiva et al., 1998; Subauste et al., 
1999).  In contrast, these interactions are not critical for production of IFN-! in the murine model, 
yet mice deficient in CD40L display increased susceptibility during chronic infection (Reichmann 
et al., 2000).  While CD40L can act synergistically with IFN-! to inhibit parasite replication, there 
is also evidence that CD40L can act independently of IFN-! (Andrade et al., 2005; Portillo et al., 
2010; Reichmann et al., 2000; Subauste and Wessendarp, 2006).  One IFN-! independent 
mechanism by which CD40L controls infection is through the induction of xenophagic killing of the 
parasite, which has been shown to be independent of the p47 GTPase family, but dependent 
upon the autophagic molecule Beclin-1 (Portillo et al., 2010; Subauste et al., 2007; Subauste and 
Wessendarp, 2006).  Beclin-1-heterozygous mice also demonstrate increased susceptibility to T. 
gondii infection, indicating that CD40-mediated xenophagy may be a unique and critical 
mechanism for controlling chronic toxoplasmosis.   
 Lymphotoxin alpha (LT-") is another member of the TNF family essential for immunity to 
T. gondii.  Like TNF and TNFR KO mice, LT-" KO mice succumb to this infection within the first 4 
weeks, associated with a high parasite burden (Schluter et al., 2003).  These mice display 
functional but delayed IFN-! responses and antibody titers, and decreased expression of iNOS.  
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These defects may conceivably result from a critical role for LT-" in signaling to directly promote 
effector functions, or they may be a secondary consequence of the defective splenic architecture 
observed in LT-" KO mice (De Togni et al., 1994).   
 Thus, cytokines and the effector mechanisms they induce are able to control 
toxoplasmosis, allowing the parasite and the host to co-exist.  Parasite virulence factors or 
immunodeficiency can disrupt this equilibrium, leading to severe disease or the death of the host.  
However, the immune effector mechanisms that control parasite burden can also bear a fitness 
cost upon the host, as will de described in the following section. 
 
Severe immunopathology and the mechanisms that prevent it 
As is true for many infections, maintaining immune homeostasis during toxoplasmosis requires 
not only the ability to limit the replication of the pathogen, but also the ability to control the host 
immune response.  In wild type mice this is illustrated by severe infection-induced inflammation in 
the gut and central nervous system that is mediated by CD4+ T cells.  This section will review the 
factors that contribute to these pathologic events and the mechanisms by which they are 
controlled.   
 
Intestinal Ileitis following infection with T. gondii   
Immunopathology can occur in the ileum following oral infection with T. gondii in mice and other 
species, and this ileitis has been proposed as a model to understand the basis for immune-
mediated gastrointestinal disease in humans (Egan et al., 2011a; Liesenfeld et al., 1996).  The 
infection-induced ileitis is characterized by the development of severe necrosis and inflammatory 
foci, and is dependent upon the host’s sex and genetic background (Liesenfeld et al., 1996; 
Liesenfeld et al., 2001).  That this process is immune mediated is demonstrated by studies in 
which C57B/6 mice lacking CD4+ T cells or mice depleted of CD4+ T cells fail to develop this 
phenotype (Liesenfeld et al., 1996).  Development of the ileitis is a complex process involving 
numerous cell types, including intraepithelial lymphocytes, natural killer T cells, and NK cells 
(Egan et al., 2009a; Egan et al., 2011b; Khan et al., 2006; Ronet et al., 2005).  Factors that 
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promote T cell responses, such as CD40/CD40L interactions and the cytokines IL-12 and IL-23 
also contribute to ileitis development (Li et al., 2002; Munoz et al., 2009; Vossenkamper et al., 
2004).  Other cytokines, such as IFN-!, TNF-", IL-18, IL-22, and the macrophage migration 
inhibitory factor (MIF) have also been implicated in mediating pathology (Cavalcanti et al., 2011; 
Liesenfeld et al., 1999; Munoz et al., 2009; Vossenkamper et al., 2004).  The Th2 cytokines IL-4 
and IL-5 have also been implicated in ileitis development, although another report found IL-4-
deficient mice to be more susceptible to oral challenge (Nickdel et al., 2004; Nickdel et al., 2001; 
Roberts et al., 1996). 
As work on this model has progressed, it has become clear that the commensal bacteria present 
in the gut contribute to the development of this infection-induced ileitis (Heimesaat et al., 2006).  
Recent findings have led to a model in which oral challenge with T. gondii results in a dramatic 
increase in the quantity of Gram-negative bacteria in the gut flora and bacterial translocation to 
subepithelial tissues (Heimesaat et al., 2006) where TLR4 senses these bacteria and amplifies 
the local inflammation (Heimesaat et al., 2007).  Additionally, mice deficient in TLR11, which 
binds to profilin expressed by the parasite, do not develop ileitis, suggesting that the innate 
response to T. gondii also contributes to this process (Benson et al., 2009).  While these findings 
implicate both parasitic and bacterial antigens in stimulating the pathologic immune response, the 
antigen specificity of the CD4+ T cells that mediate ileitis remains to be determined.  
 
CD4+ T cell mediated immunopathology during Toxoplasmic encephalitis 
Another example of severe pathology occurs in mouse models of chronic toxoplasmic 
encephalitis.  Although CD4+ T cells are essential for long-term resistance to T. gondii, they also 
can induce severe pathology in the central nervous system.  Thus, in susceptible mice large 
numbers of CD4+ T cells are present in the brain during the chronic encephalitis, and depletion of 
CD4+ T cells can ameliorate pathology without affecting parasite burden (Israelski et al., 1989).  
Similarly, CD28 KO mice infected with T. gondii have normal parasite burdens but exhibit 
enhanced resistance to toxoplasmic encephalitis that correlates with decreased numbers of CD4+ 
T cells in the brain (Reichmann et al., 1999).  This work contrasts with studies in which depletion 
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of CD4+ T cells was sufficient to reactivate disease (Vollmer et al., 1987).  These seemingly 
conflicting results may be partially explained by differences in depletion efficiency, as complete 
depletion of CD4+ T cells in the central nervous system can be difficult to obtain, and is not 
necessarily reflected by the depletion efficiency in other tissue sites (Wilson et al., 2005).  Thus, 
while CD4+ T cells are required for control of infection, partial inhibition of CD4+ T cell responses 
may be beneficial to the host in the context of chronic toxoplasmic encephalitis. 
 
IL-10 inhibits CD4+ T cell mediated immunopathology 
Since 1996, the use of various knockout mice has led to the identification of factors critical for 
limiting the development of immune pathology during toxoplasmosis.  These studies have 
provided a novel insight into the nature of host-pathogen interactions, which is perhaps best 
illustrated by studies in which mice deficient in the cytokine IL-10 (IL-10 KO) were challenged with 
T. gondii (Gazzinelli et al., 1996b).  IL-10 is produced by a number of cell types, including 
macrophages, NK cells, T cells and B cells, and functions by inhibiting the activation of accessory 
cells and adaptive immune responses (Moore et al., 2001).  The central role for IL-10 in limiting 
inflammation was confirmed by the finding that IL-10 KO mice develop spontaneous colitis (Kuhn 
et al., 1993).  However, IL-10 is also a potent antagonist of the ability of macrophages to kill 
intracellular bacteria and parasites, such as T. gondii, and infection with a number of pathogens, 
including T. gondii, increases expression of IL-10 (Gazzinelli et al., 1993a; Gazzinelli et al., 
1992b; Hunter et al., 1993; Khan et al., 1995; Sher et al., 1992).  These findings led to the idea 
that pathogens induce IL-10 production as a means to evade the immune response (Sher et al., 
1992).  However, challenge of IL-10 KO mice with T. gondii revealed that these mice display 
normal parasite burdens, but develop severe liver damage, increased production of pro-
inflammatory cytokines, and succumb to a CD4+ T cell mediated hyper-inflammatory response 
(Gazzinelli et al., 1996b).  These results provide one of the first examples of an infection in which 
the host must control its own immune response and tolerate pathogen persistence in order to 
survive. 
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 While IL-10 is clearly critical for survival during the acute stage of infection, studies 
analyzing the role of IL-10 during toxoplasmic encephalitis have yielded more ambiguous results.  
There is general agreement that IL-10 expression is upregulated in the brain during chronic 
toxoplasmosis, and macrophages and CD4+ T cells represent a local source of IL-10 in the 
central nervous system (Deckert-Schluter et al., 1997; Wilson et al., 2005).  One study observed 
that neutralization of IL-10 during chronic toxoplasmosis was not lethal to infected mice, and 
resulted in decreased parasite burden (Deckert-Schluter et al., 1997).  In contrast, another study 
reported that blocking of the IL-10R resulted in decreased survival of chronically infected mice 
(Jankovic et al., 2007).  Similarly, in a system that allowed IL-10 KO mice to survive acute 
infection, the chronically infected IL-10 KO mice displayed normal parasite burden but also 
developed severe immunopathology mediated by CD4+ T cells associated with increased 
production of pro-inflammatory cytokines (Wilson et al., 2005).  Together, these results suggest 
that while IL-10 may partially inhibit effector mechanisms that could otherwise reduce parasite 
burden, it is crucial in the acute and chronic stage of infection to prevent severe 
immunopathology.  
 Attempts to identify the cellular sources of IL-10 during toxoplasmosis have revealed that 
there are multiple contributors, including macrophages (Deckert-Schluter et al., 1997), NK cells 
(Perona-Wright et al., 2009), CD4+ T cells (Deckert-Schluter et al., 1997; Jankovic et al., 2007) 
and CD8+ T cells (Deckert-Schluter et al., 1997).  Innate sources of IL-10 are significant during 
toxoplasmosis, as the loss of IL-10 expression from SCID mice can dramatically extend their 
survival (Neyer et al., 1997), and NK cells are regarded as a major innate source of IL-10 during 
the acute stage of infection (Perona-Wright et al., 2009).  Nevertheless, the use of a cre-lox 
system to selectively eliminate IL-10 production from CD4+ and CD8+ T cells revealed that these 
mice still develop severe immunopathology upon infection (Roers et al., 2004), indicating that 
non-T cell sources of IL-10 were not sufficient to limit pathology.  Subsequent work has 
demonstrated that depletion of CD4+ T cells dramatically decreases expression of IL-10, and that 
the CD4+ T cells that produce IL-10 express the transcription factor T-bet and low levels of CD25, 
which was interpreted to suggest that they were effector T cells as opposed to regulatory T cells 
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(Jankovic et al., 2007). However, the recent identification of a population of T-bet+ Foxp3+ 
population of regulatory T cells that produce IL-10 during toxoplasmosis calls this interpretation 
into question (Hall et al., 2012).   
 
IL-27 inhibits CD4+ T cell mediated immunopathology  
IL-27 is another cytokine critical for regulating CD4+ T cell responses during toxoplasmosis.  Initial 
reports concluded that the IL-27 receptor was important in promoting Th1 immune responses 
(Watford et al., 2003), however when mice deficient in WSX1, a component of the IL-27 receptor, 
were infected with T. gondii, these mice were found to exhibit enhanced Th1 responses and 
dramatically increased susceptibility to this challenge (Villarino et al., 2003).  Similar to the IL-10 
KO mice, infected WSX1 KO mice have normal parasite burdens but develop severe liver and 
lung pathology, and increased numbers of activated CD4+ and CD8+ T cells.  Furthermore, 
depletion of CD4+ T cells prevents the infection-induced pathology.  Although initial studies 
indicated that the suppressive effects of IL-27 were independent of IL-10 (Villarino et al., 2003), 
subsequent work has demonstrated that IL-27 promotes IL-10 expression (Stumhofer et al., 
2007).  However, this property of IL-27 does not fully explain its suppressive activities.  IL-27 can 
also act directly on CD4+ T cells to inhibit production of IL-2, a growth and survival factor for T 
cells, and neutralization of IL-2 results in enhanced survival of WSX1-KO mice (Villarino et al., 
2003).  Another recent study found that deficiency in EBI3, a component of IL-27, correlated with 
decreased expression of the inhibitory molecule PD-L1 on CD4+ T cells during toxoplasmosis, 
providing another potential mechanism by which IL-27 may mediate its protective effects 
(Hirahara et al., 2012). 
 Although WSX1 KO mice normally do not survive to chronic infection, treatment with anti-
toxoplasma drugs or immune blockade can prevent acute susceptibility, allowing the role of IL-27 
during chronic infection to be examined (Stumhofer et al., 2006). Under these circumstances, 
WSX1 KO mice show no defect in their ability to control parasite burden but do develop severe 
immunopathology in the central nervous system, which correlated with decreased production of 
IL-10 and increased production of IL-17 (Stumhofer et al., 2006; Stumhofer et al., 2007).  These 
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findings led to the recognition that IL-27 can directly inhibit production of IL-17 from Th17 cells 
(Stumhofer et al., 2006).  These results collectively support a model in which IL-27 controls 
immunopathology during toxoplasmosis by inhibiting multiple facets of T cell activation, and the 
principles established using T. gondii have been shown to be relevant to the immunosuppressive 
effects of IL-27 in a variety of systems, including infections with other intracellular parasites 
(Hamano et al., 2003; Rosas et al., 2006), helminth infection (Artis et al., 2004), bacterial infection 
(Pearl et al., 2004) (Holscher et al., 2005), and numerous autoimmune models (Amadi-Obi et al., 
2007; Batten et al., 2006; Fitzgerald et al., 2007; Stumhofer and Hunter, 2008; Troy et al., 2009; 
Villarino et al., 2008).  
 
The role of Ahr and Lipoxin in controlling immunopathology  
Another factor that contributes to the control of chronic toxoplasmosis is Lipoxin A4 (LXA4), a 
product of the reaction catalyzed by the enzyme 5-lipoxygenase (5LO).  Mice deficient in 5LO 
succumb to toxoplasmosis approximately one month post infection, having reduced parasite 
burdens relative to wild type controls (Aliberti et al., 2002b).  5LO-deficiency is associated with 
increased infiltration of inflammatory cells into the brain, and elevated production of the cytokines 
IL-12, IFN-!, and TNF-".  Expression of LXA4 is induced by infection with T. gondii and 
administration of an LXA4 analogue can rescue 5LO-deficient mice, implicating this molecule as a 
negative regulator of inflammation.  One known mechanism by which LXA4 can inhibit immune 
responses is by serving as a ligand for the aryl hydrocarbon receptor (Ahr) (Schaldach et al., 
1999).  Ahr is an intracellular signaling molecule that translocates to the nucleus upon binding to 
its ligand (Abel and Haarmann-Stemmann, 2010).  Ligation of Ahr by LXA4 inhibits the production 
of IL-12 from DCs in a manner dependent upon the signaling molecule Suppresser of Cytokine 
Signaling 2 (SOCS2), which is also required for survival during toxoplasmosis (Aliberti et al., 
2002a; Machado et al., 2006).  Consistent with this mechanism as a means to control the immune 
response during toxoplasmic encephalitis, mice deficient in Ahr have reduced parasite burdens, 
but succumb to chronic infection with T. gondii (Sanchez et al., 2010).   
 
!
!
27 
Other factors involved in controlling immune pathology 
TLR11 is another factor necessary to control the immune response during acute toxoplasmosis 
(Yarovinsky et al., 2008).  In the absence of TLR11, mice develop fat necrosis and pancreatic 
inflammation, which does not correlate with increased parasite burden in the pancreas.  This 
inflammation is mediated by IL-12, IFN-! and NK cells, but is independent of T lymphocytes.  The 
cytokines IL-18 and IL-1# are also partially responsible for the development of pancreatic 
inflammation, as neutralization of either of these cytokines decreases inflammation. These results 
raise the question as to what anti-inflammatory mechanisms may be initiated by TLR11 ligation.  
Given the prominent role of IL-12 in eliciting production of IL-10 from NK cells (Perona-Wright et 
al., 2009), it may be that decreased IL-12 levels in the absence of TLR11 result in insufficient 
amounts of IL-10 to prevent pancreatic pathology, although additional experiments are required to 
test this model. 
 Another pathway involved in protection of mice against severe immunopathology during 
acute toxoplasmosis involves the cleavage of fibrinogen to produce fibrin, as part of the cascade 
responsible for blood clotting (Furie and Furie, 1988).  Fibrin levels are increased upon infection 
with T. gondii in a TNF-" dependent manner, while IFN-! negatively regulates these events 
(Mullarky et al., 2006).  Mice lacking fibrin exhibit normal control of parasite burden and intact 
immune responses, but succumb to infection within the first 15 days, associated with an IFN-! 
dependent liver pathology characterized by necrosis, hemorrhaging, and diffuse inflammatory 
infiltrates (Johnson et al., 2003).  Thus, fibrin prevents hemorrhaging and severe pathology during 
toxoplasmosis. 
 
Summary 
While this chapter has summarized much of the current knowledge of toxoplasmosis, it has also 
highlighted areas of ambiguity in the literature. Although evidence suggests that CD8" dendritic 
cells are critical for generating adaptive immune responses, the roles of myeloid dendritic cells 
and plasmacytoid dendritic cells in this process are less clear. Furthermore, although an infection-
induced increases in numbers of dendritic cells have been observed, it is unclear what factors 
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regulate dendritic cell homeostasis during infection. The specific types of interactions between 
parasites and host cells (e.g. active inavasion or phagocytosis) that lead to antigen presentation 
are also unknown. Chapter 2 of this thesis will explore the role of Flt3L, a cytokine known to be 
involved in dendritic cell homeostasis, in immunity to T. gondii. In Chapter 3, the specific 
interactions between parasites and host cells necessary for the generation of adaptive immunity 
will be explored. Lastly, the findings from these chapters will be discusses in the context of the 
current understanding of toxoplasmosis, their potential applications to medicine, and future 
directions for research in this field.  
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Cytokines Sources Phenotype of knockout Functions 
• IL-12 • Dendritic cells 
(Hou et al., 
2011; Liu et 
al., 2006; 
Mashayekhi et 
al., 2011) 
• Neutrophils  
(Bliss et al., 
1999a; Bliss et 
al., 1999b; 
Whitmarsh et 
al., 2011) 
• Inflammatory 
monocytes 
(Mordue and 
Sibley, 2003; 
Whitmarsh et 
al., 2011) 
• Macrophages 
(Gazzinelli et 
al., 1996b; 
Mordue and 
Sibley, 2003; 
Whitmarsh et 
al., 2011) 
• Succumb within 10 days 
of infection (Gazzinelli et 
al., 1994; Yap et al., 
2000) 
• Inability to control 
parasite burden 
(Gazzinelli et al., 1994; 
Yap et al., 2000) 
• Promotes T cell 
proliferation and 
differentiation 
(Gazzinelli et al., 
1994; Wilson et 
al., 2008) 
• Promotes Natural 
Killer cell 
responses 
(Gazzinelli et al., 
1993b; Hunter et 
al., 1994) 
• Promotes IFN-! 
production 
(Gazzinelli et al., 
1993b; Gazzinelli 
et al., 1994) 
• Promotes IL-10 
expression from 
natural killer cells 
(Perona-Wright et 
al., 2009) 
• IFN-! • Natural killer 
cells (Denkers 
et al., 1993; 
Hunter et al., 
1994; Johnson 
et al., 1993; 
Sher et al., 
1993) 
• CD4+ T cells 
(Gazzinelli et 
al., 1992a) 
• CD8+ T cells 
(Gazzinelli et 
al., 1992a) 
• Succumb within 10 days 
of infection (Suzuki et 
al., 1988) 
• Inability to control 
parasite burden (Suzuki 
et al., 1988) 
• Promotes iNOS 
expression 
(Adams et al., 
1990) 
• Promotes p47 
GTPase-
mediated killing of 
T. gondii (Howard 
et al., 2011; 
Taylor et al., 
2000) 
• Promotes 
Tryptophan 
degradation 
(Daubener et al., 
1996; Daubener 
et al., 2001; 
Murray et al., 
1989; Pfefferkorn, 
1984) 
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• TNF-" • Neutrophils 
(Bennouna et 
al., 2003; Bliss 
et al., 1999a) 
• Dendritic cells 
(Bennouna et 
al., 2003) 
• Macrophages 
(Li et al., 
1994) 
• Microglia 
(Schluter et 
al., 2001) 
• T cells 
(Schluter et 
al., 1997) 
• Succumb ~3-4 weeks 
post-infection (Deckert-
Schluter et al., 1998; 
Schluter et al., 2003; 
Yap et al., 1998) 
• Inability to control 
parasite burden 
(Deckert-Schluter et al., 
1998; Schluter et al., 
2003; Yap et al., 1998) 
• Promotes 
macrophage 
activation (Chang 
et al., 1990) 
• Promotes control 
of parasite in non-
hematopoietic 
cells (Yap and 
Sher, 1999) 
• Promotes iNOS 
expression 
(Deckert-Schluter 
et al., 1998; 
Gazzinelli et al., 
1993a; 
Langermans et 
al., 1992; 
Schluter et al., 
2003) 
 
• IL-6 • Monocytes  
(Pelloux et al., 
1994) 
• Astroglia  
(Fischer et al., 
1997) 
• Stromal cells 
(Chou et al., 
2012) 
• Retinal 
pigment 
epithelial cells 
(Nagineni et 
al., 2000) 
• Increased susceptibility 
2-4 weeks post-infection 
(Jebbari et al., 1998) 
• Increased parasite 
burden (Jebbari et al., 
1998; Suzuki et al., 
1997) 
• Necessary for 
optimal neutrophil 
responses 
(Jebbari et al., 
1998) 
• Necessary for 
optimal IFN-! 
responses 
(Jebbari et al., 
1998; Suzuki et 
al., 1997) 
 
• LT- " • Lymphocytes  
(Browning et 
al., 1997) 
• Succumb 2-4 weeks 
post-infection (Schluter 
et al., 2003) 
• Necessary for 
normal secondary 
lymphoid 
architecture (De 
Togni et al., 
1994) 
• Necessary for 
optimal antibody 
and IFN-! 
responses early 
during infection 
(Schluter et al., 
2003) 
• Necessary for 
optimal 
expression of 
iNOS (Deckert-
Schluter et al., 
1998) 
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Table 1.1.  Cytokines involved in immunity to T. gondii. 
 
 
• IL-10 • Natural killer 
cells (Perona-
Wright et al., 
2009) 
• Macrophages 
(Deckert-
Schluter et al., 
1997) 
• CD4+ T cells 
(Jankovic et 
al., 2007) 
• CD8+ T cells 
(Deckert-
Schluter et al., 
1997) 
• Succumb 1-2 weeks 
post-infection (Gazzinelli 
et al., 1996b) 
• Severe 
immunopathology 
(Gazzinelli et al., 1996b) 
• Inhibits CD4+ T 
cell-mediated 
pathology 
(Gazzinelli et al., 
1996b) 
• IL-27 • Antigen 
Presenting 
Cells (Pflanz 
et al., 2002) 
• Succumb within 15 days 
post-infection (Villarino 
et al., 2003) 
• Severe 
immunopathology 
(Villarino et al., 2003) 
• Inhibits IL-17 
production 
(Stumhofer et al., 
2006) 
• Inhibits IL-2 
production 
(Villarino et al., 
2003) 
• Promotes IL-10 
production 
(Stumhofer et al., 
2007) 
• Promotes PD-L1 
expression 
(Hirahara et al., in 
press, 2012) 
• CD40L 
(Surface 
protein) 
• Expressed on 
T cells 
(Banchereau 
et al., 1994) 
• Succumb 30-80 days 
post-infection 
(Reichmann et al., 2000) 
• Inability to control 
parasite burden 
(Reichmann et al., 2000) 
• Promotes Th1 
responses in 
humans 
(Subauste et al., 
1999) 
• Promotes iNOS 
expression (Jana 
et al., 2001) 
• Promotes 
xenophagic killing 
of T. gondii 
(Portillo et al., 
2010) 
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Figure 1.1:  Immune response to T. gondii.  During toxoplasmosis, TLRs 2,4, 11 and 12 sense 
T. gondii, and other unidentified TLR-independent mechanisms are likely involved as well.  In 
response to the parasite, innate immune cells such as dendritic cells produce IL-12 and present 
antigen to CD4+ and CD8+ T cells.  IL-12 drives the production of IFN-! from CD4+ T cells, CD8+ 
T cells and NK cells.  IFN-! mediates anti-parasitic effector mechanisms in infected host cells. 
  
!"#$%&'(')*+,-)$
.))+*'$.//0)'$
1'22($
3456$
3476$
.89:;$
.<=9>$
=?$
@8A($
@8A9
B)C'D')C')*$
/'1E+)B(/(F$
!
!
33 
 
Figure 1.2:  Potential antigen presentation pathways.  A.  Antigen may be acquired through 
the phagocytosis of infected cells, intact parasites, parasite antigens, or through the endocytosis 
of parasite debris.  B.  Antigen may also be acquired by infected cells through the release of 
soluble antigens from the parasite, or through the sampling of antigens from the parasitophorous 
vacuole, which may be mediated by fusion of the parasitophorous vacuole with the endoplasmic 
reticulum.  Antigens may also be injected into the host cell through abortive invasion events. 
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CHAPTER 2:  DEFICIENCY IN FLT3L LEADS TO ACUTE SUSCEPTIBILITY TO 
TOXOPLASMOSIS 
Abstract 
Toxoplasma gondii is an intracellular protozoan parasite and a prominent cause of disease in 
patients with inherited or acquired deficiencies in T cells.  Dendritic cells (DCs) are critical for 
immunity to this parasite, however little is known about the factors that regulate DC homeostasis 
during infection.  The cytokine fms-like tyrosine kinase-3 ligand (Flt3L) is a growth factor that 
promotes dendritic cell development, and challenge of mice with T. gondii is associated with 
increased numbers of DCs that express the receptor for Flt3L (Flt3). When mice deficient in Flt3L 
(Flt3L KO mice), which have basal defects in numbers of DCs, were infected with an avirulent 
strain of T. gondii, they displayed increased growth of parasites and susceptibility to acute 
infection. This phenotype correlated with decreased production of the cytokines IL-12 and 
interferon-gamma (IFN-!), and impaired natural killer cell responses. Surprisingly, infection of 
Flt3L KO mice induced increased numbers of DCs, and expansion of parasite-specific CD4+ and 
CD8+ T cells, however these T cells were impaired in their ability to produce IFN-!.  Finally, 
despite marked defects in the numbers of DCs in the Flt3L KO mice, the administration of 
exogenous IL-12 alone was sufficient to prevent acute susceptibility. Together, these results 
highlight the importance of the Flt3L pathway for the development of DCs required for resistance 
to toxoplasmosis, but demonstrate that there are Flt3L-independent pathways that are sufficient 
to prime CD4+ and CD8+ T cells capable of controlling acute toxoplasmosis. 
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Introduction   
Toxoplasma gondii is an intracellular protozoan parasite of medical and veterinary importance 
(Dubey, 2008).  Successful control of this infection requires a Th1 immune response, 
characterized by the production of the cytokine IL-12 from innate myeloid cells such as dendritic 
cells (DCs), which drives the production of interferon-gamma [IFN-!] from natural killer (NK) cells, 
CD4+ T cells and CD8+ T cells (Gazzinelli et al., 1992a; Gazzinelli et al., 1994; Suzuki et al., 
1988). IFN-!, in combination with other inflammatory signals, acts directly on infected host cells to 
induce anti-microbial effector mechanisms that can kill the parasite or limit its ability to replicate 
(Dupont et al., 2012).  Although NK cells serve as a source of IFN-! during acute infection, 
production of IFN-! from CD4+ and CD8+ T cells is required for long-term protection (Gazzinelli et 
al., 1993b; Gazzinelli et al., 1994; Hunter et al., 1994). 
  With the recognition that IL-12 was critical for innate and adaptive immunity to T. gondii, 
there has been an interest in defining the cellular sources of this cytokine and understanding how 
these cells sense the parasite. To date, Toll-like receptors (TLR) 2,4,11, and 12, as well as the 
chemokine receptor CCR5 have all been proposed to directly sense parasite antigens (Aliberti et 
al., 2000; Debierre-Grockiego et al., 2007; Koblansky et al., 2013; Yarovinsky et al., 2005). 
Additionally, multiple cellular sources of IL-12 during toxoplasmosis have been identified that 
include neutrophils (Egan et al., 2008), inflammatory monocytes (Goldszmid et al., 2012), 
macrophages (Gazzinelli et al., 1996b), plasmacytoid DCs (Koblansky et al., 2013; Pepper et al., 
2008) and CD8"+ DCs (Mashayekhi et al., 2011; Reis e Sousa et al., 1997). Regardless, there is 
strong evidence that DCs are a critical source of IL-12, as mice in which DCs are selectively 
depleted or those in which DCs lack the TLR signaling molecule MyD88 have reduced IL-12 
production and are acutely susceptible to toxoplasmosis (Hou et al., 2011; Scanga et al., 2002).  
Other studies have shown that the administration of Soluble T. gondii Antigen (STAg) induces IL-
12 production predominantly by CD8" DCs (Reis e Sousa et al., 1997). Furthermore, Batf3 KO 
mice, which lack CD8" DCs, infected with T. gondii display impaired IL-12 production and 
increased susceptibility to this challenge (Mashayekhi et al., 2011). In contrast to these studies, a 
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recent report concluded that CD11bHI DCs derived from inflammatory monocytes were the major 
source of IL-12 in vivo (Goldszmid et al., 2012).  
 While there is strong evidence that DCs have an important role in resistance to T. gondii, 
little is known about the host factors that influence their homeostasis during this infection. Multiple 
reports have established that in mice challenged with T. gondii, there are increased numbers of 
plasmacytoid DCs in lymphoid tissues, accumulation of CD11bHI DCs at the site of infection and 
in the draining lymph nodes, and expansion of CD8" DCs in the spleen (Mashayekhi et al., 2011; 
Pepper et al., 2008; Tait et al., 2010).  These changes may result from increased migration of 
DCs to these sites, the development of inflammatory monocytes into DCs, increased proliferation 
or survival of DCs, or increased differentiation and proliferation of DC precursor cells (Liu and 
Nussenzweig, 2010).  Indeed, there is evidence that monocytes develop into CD11bHI DCs during 
toxoplasmosis (Goldszmid et al., 2012), and recent work has identified a Batf3-independent 
pathway by which inflammation can induce the development of CD8" DCs (Tussiwand et al., 
2012).  
 One of the key cytokines that regulates DC development and homeostasis is Fms-like 
tyrosine kinase-3 ligand (Flt3L), which promotes the differentiation and proliferation of dendritic 
cell precursors, as well as the expansion of mature DCs (Watowich and Liu, 2010). Flt3L can 
exist in a soluble or transmembrane form, and is expressed by bone marrow stromal cells and 
mast cells, as well as numerous other cell types whereas its receptor, Flt3, is expressed on 
dendritic cell precursors and mature DCs (Bertho et al., 2008; Lim et al., 2012; Lyman and 
Jacobsen, 1998).  While Flt3L has been most prominently linked to DC development, there is 
evidence that it also impacts the function of DCs. Thus, Flt3L has been proposed to extend the 
period of antigen presentation by promoting the proliferation of antigen-presenting DCs (Liu et al., 
2007), and has been shown to promote dendritic cell-mediated activation of NK cells 
(Eidenschenk et al., 2010).   
 In order to better understand the factors that influence DC homeostasis during infection, 
studies were performed to assess the role of Flt3L-dependent DC populations in resistance to T. 
gondi. Infection with T. gondii induced the expansion of Flt3+ve DCs, and mice deficient in Flt3L 
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(Flt3L KO mice) were unable to control early parasite burden. This phenotype correlated with 
decreased production of IL-12 and IFN-!, reduced numbers of IL-12-producing DCs at the site of 
infection, and impaired NK cell responses.  Surprisingly, infection of Flt3L KO mice did result in a 
significant increase in DCs, associated with the expansion of parasite-specific CD4+ and CD8+ T 
cell populations, however the ability of these T cells to produce IFN-! was impaired. Lastly, Flt3L 
KO mice could be rescued by the administration of exogenous IL-12, thus highlighting the role of 
DCs as a source of IL-12 during toxoplasmosis, and demonstrating that DC expansion and 
priming of naïve T cells can occur independently of Flt3L. 
 
Materials and Methods 
Ethics Statement All procedures involving mice were reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of Pennsylvania (Animal Welfare Assurance 
Reference Number #A3079-01) and were in accordance with the guidelines set forth in the Guide 
for the Care and Use of Laboratory Animals of the National Institute of Health. 
Mice Flt3L KO and C57BL/6 mice were obtained from Taconic Farms (Germantown, NY).  All 
mice were kept in specific-pathogen-free conditions at the School of Veterinary Medicine at the 
University of Pennsylvania. 
Infections  All infections were performed with 103 Pru-OVA parasites or Pru-OVA-Tomato 
parasites, which have been previously described (John et al., 2009; Pepper et al., 2004). 
Parasites were cultured and maintained by serial passage on human foreskin fibroblast cells in 
the presence of parasite culture media [71.7% DMEM (Corning), 17.9% Medium 199 (Invitrogen), 
9.9% Fetal Bovine Serum (FBS)(Invitrogen), 0.45% Penicillin and Streptomycin (Invitrogen)(final 
concentration of 0.05 units/ml Penicillin and 50 µg/ml Streptomycin), 0.04% Gentamycin 
(Invitrogen)(final concentration of 0.02 mg/ml Gentamycin)]. For infections, parasites were 
harvested and serially passaged through 18, 20 and 26 gauge needles (BD) before filtration with 
a 5 µM filter (Sartorius Stedim). Parasites were washed extensively with PBS and mice were 
injected intraperitoneally with 103 parasites suspended in PBS.  IL-12 was obtained from 
PeproTech.   
!
!
38 
Cell culture and tissue harvesting Peritoneal exudate cells (PECS) were obtained by peritoneal 
lavage with 5 ml of PBS. Splenocytes were obtained by grinding spleens over a 40 µM filter 
(Biologix) and washing them in complete media. Red blood cells were then lysed by incubating 
for 5 minutes at room temperature in 5 ml of lysis buffer [0.864% ammonium chloride (Sigma-
Aldrich) diluted in sterile de-ionized H2O)], followed by washing with complete media. Bone 
marrow-derived macrophages were obtained using previously described methods (Robben et al., 
2004; Whitmarsh et al., 2011).  For experiments in which cells were restimulated to measure 
cytokine levels, cells were incubated in complete media in the presence of Brefeldin A (0.01 
mg/ml), with or without PMA (0.1 µg/ml) and ionomycin (0.1 µg/ml) for four hours. 
Flow Cytometry  Cells were washed with FACS Buffer [1x PBS, 0.2% bovine serum antigen 
(Sigma), 1 mM EDTA (Invitrogen)], stained with LIVE/DEAD® Fixable Aqua Dead Cell marker 
(Invitrogen) and incubated in Fc block [99.5% FACS Buffer, 0.5% normal rat serum (Invitrogen), 1 
µg/ml 2.4G2 (BD)] prior to staining. APC-MHCI-SIINFEKL Tetramer was obtained from Beckman-
Coulter.  PE-MHCI-SVLAFRRL was obtained as a generous gift from the NIH Tetramer Core 
Facility.  The following antibodies were used for staining: Ki67 Alexa Fluor®488 (BD, B56), CD3 
APC-eFluor®780 (eBioscience, 17A2), CD8 eFluor®450 (eBioscience, 53-6.7), CD11a PerCP-
Cy5.5 (Biolegend, H155-78), MHCII PE (eBioscience, M5/114.15.2), NK1.1 PE (BD, PK136), 
CD19 PE (eBioscience, 1D3), Foxp3 eFluor®450 (eBioscience, FJK-16a), CD4 Pe-Cy7 
(eBioscience, GK1.5), CD3 FITC (BD, 145-2C11), NK1.1 FITC (eBioscience, PK136), CD19 FITC 
(eBioscience, 1D3), Gr-1 PerCP-Cy5.5 (eBioscience, RB6-8C5), CD11c PE-Cy7 (eBioscience, 
N418), CD11b APC-eFluor®780 (eBioscience, M1/70), MHCII AF700 (Biolegend, M5/114.15.2), 
MHCII Pacific Blue (BioLegend, M5/114.15.2), PE Flt3 (eBioscience, A2F10), eFluor®660 Ly6g 
(eBioscience, 1A8), Alexa Fluor® IL-12p40 (eBioscience, C17.8), FITC DX5 (BD, DX5), 
eFluor®660 NKp46 (eBioscience, 29A1.4), Alexa Fluor®647 T-bet (BioLegend, 4B10), Pe-Cy7 
IFN-! (eBioscience, XMG1.2). Intracellular staining for transcription factors was performed using 
the Foxp3/ Transcription Factor Staining Buffer Set (eBioscience) following the manufacturer’s 
instructions. Intracellular cytokine staining was performed by fixing cells in 2% paraformaldehyde, 
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followed by permeabalization and staining in 0.5% saponin (Sigma-Aldrich). Samples were run on 
a FACSCanto (BD) or LSR Fortessa (BD) and analyzed using FlowJo Software (TreeStar).  
ELISAs  IL-12p40 was measured by ELISA using C17.8 and biotinylated C15.6 antibodies.  IFN-! 
was measured by ELISA using AN18 and biotinylated R4-6A2 (eBioscience) antibodies.  Flt3L 
was measured using the Mouse/Rat Flt-3 Ligand Quantikine ELISA Kit. 
Statistical Analysis  Statistical analysis was performed using PRISM software (Graphpad 
Software). Significance was calculated using an unpaired two-tailed student’s t-test except when 
otherwise noted.  *p<0.05; **p<0.005; ***p<0.0005.    
 
Results 
Infection induced changes in Flt3-expressing dendritic cells  
Given the marked changes in DC populations observed during toxoplasmosis (Mashayekhi et al., 
2011; Pepper et al., 2008; Tait et al., 2010), and the known role of Flt3L in DC homeostasis (Liu 
and Nussenzweig, 2010), experiments were performed to assess how infection with T. gondii 
affected expression of Flt3L and Flt3. When C57Bl/6 mice were challenged using the Pru strain of 
T. gondii and examined at day 5 post-infection, Flt3L was detectable in the sera of these mice at 
levels similar to those in naïve mice (Figure 2.1a). Expression of Flt3 could be detected on 
peritoneal DCs from naïve and infected mice, but not on macrophages, neutrophils or monocytes 
(Figure 2.1b). Two distinct populations of DCs could be distinguished on the basis of Flt3 
expression (Flt3LOW and Flt3HI), and consistent with previous reports (Ginhoux et al., 2009), 
Flt3LOW cells displayed high levels of CD11b, whereas Flt3HI cells displayed relatively lower levels 
of CD11b (Figure 2.1c). Infection induced no changes in the level of Flt3 expression on either the 
Flt3LOW or Flt3HI DC populations (Figure 2.1d). Although no significant changes in numbers of 
Flt3LOW DCs were apparent, infection induced a significant increase in numbers of Flt3HI DCs at 
the site of infection (Figure 2.1e). Similar results were apparent when Flt3 expression on splenic 
DCs was examined (data not shown). 
 
 
!
!
40 
Flt3L KO mice are unable to control infection with T. gondii 
When wild type (WT) and Flt3L KO mice were infected intraperitoneally with the Pru strain of T. 
gondii, all WT mice survived challenge, whereas the majority of Flt3L KO mice succumbed to 
infection within 12 days (Figure 2.2a). To understand the basis of this phenotype, Flt3L KO and 
wild-type mice were infected and sacrificed at day 8 post-infection to assess parasite burden and 
pathology.  At this time point, Flt3L KO mice demonstrated a major increase in the parasite 
burden based on the percentage of infected cells, as determined by examining cells obtained 
from the peritoneal cavity by microscopy, and by using fluorescently-labeled parasites to measure 
parasite burden in the spleen (Figure 2.2b).  Elevated parasite burdens were detected in the 
livers and lungs of Flt3L KO mice (data not shown). Histological examination of these tissues in 
the WT and Flt3L KO typically revealed areas of inflammation associated with the presence of 
parasites, but these were more severe in the Flt3L KO mice. However, in the liver there were also 
sites of extra-medullary hematopoiesis that were prominent in the WT mice – but these were 
markedly reduced in the Flt3L KO mice (Figure 2.2c). Collectively, these results establish that 
Flt3L KO mice are unable to control parasite burden. 
 
Impaired dendritic cell responses in Flt3L KO mice  
To assess the cause of the increased susceptibility of Flt3L KO mice to toxoplasmosis, levels of 
the cytokines IL-12 and IFN-! were measured in the sera on day 8 post-infection. Deficiency in 
Flt3L was associated with significantly decreased levels of both IL-12 (60.0% reduction; p<0.005) 
and IFN-! (45.7% reduction; p<0.05)(data not shown).  To assess DC responses infected WT 
and KO mice were sacrificed at day 5 post-challenge, a time point when infection rates in the 
PECS were typically less than 0.5% in WT mice and 2% in Flt3L KO mice (data not shown). 
While infection with T. gondii was found to induce a significant increase in numbers of DCs at the 
site of infection in both WT and Flt3L KO mice, numbers of DCs were reduced in infected Flt3L 
KO mice, relative to WT controls (Figure 2.3a). In contrast, infection-induced increases in 
neutrophils, monocytes and macrophages were intact in Flt3L KO mice (data not shown). 
Examination of IL-12 production by intracellular cytokine staining revealed that neutrophils (CD3-
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veCD19-veNK1.1-veCD11cLOWLy6g+ve) and macrophages (CD3-veCD19-veNK1.1-veCD11cLOWLy6g-
veCD11bINT-HI) were minor sources of IL-12 at the local site of infection (data not shown) and that 
DCs (CD3-veCD19-veNK1.1-veCD11cHIMHCIIHI) were the major sources of IL-12 in WT mice 
(Figure 2.3b). Nevertheless, Flt3L KO mice were found to produce less IL-12 on a per-cell basis, 
resulting in a significant reduction in the number of total IL-12-producing cells in the peritoneal 
cavities of Flt3L KO mice (Figure 2.3c). IL-12-producing DCs in WT mice were negative for CD8" 
(very few CD8"+ DCs could be isolated from the peritoneal cavity) and tended to display low 
levels of CD11b (Figure 2.3d). Due to the scarce nature of IL-12+ DCs in the peritoneal exudate 
cells (PECS) of Flt3L KO mice, these cells could not be phenotypically examined. Numbers of IL-
12-producing DCs were also reduced in the spleens of infected Flt3L KO mice when compared to 
WT mice (data not shown).  
 In addition to the infection-induced increase in dendritic cell number apparent in the 
peritoneal cavity at day 5, an increase in numbers of DCs was also apparent in the spleens of WT 
and FLt3L KO mice at day 8 post infection, but not at any earlier time points examined (Figure 
2.4a, data not shown).  Despite this, total numbers of splenic DCs were reduced in both naïve 
and infected Flt3L KO mice, relative to WT controls. Numbers of DCs belonging to each individual 
subset examined (CD11bHI DCs, CD8"+ DCs, CD11bLOW CD8"-ve DCs) increased in both infected 
Flt3L KO and infected WT mice (relative to naïve controls), although the composition of the total 
dendritic cell population varied between WT and Flt3L KO mice, as a larger percentage of DCs 
were CD11bHI in Flt3L KO mice than in WT mice (Figure 2.4a,b). These results demonstrate that 
the infection-induced increase in numbers of splenic DCs can occur independently of Flt3L, and 
suggest that the underlying defect in DC numbers in Flt3L KO mice contributes to the overall 
defect in IL-12 production. 
 
Impaired NK cell responses in Flt3L KO mice 
Since IL-12 promotes NK cell production of IFN-! during toxoplasmosis, the NK cell response in 
WT and Flt3L KO mice was compared to determine if defects in this population contribute to the 
systemic defect in IFN-! present in infected Flt3L KO mice. Similar to previous reports  (Guimond 
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et al., 2010; McKenna et al., 2000), naïve Flt3L KO mice exhibited decreased numbers of NK 
cells relative to wild type controls (Figure 2.5a).  This defect was not restored by infection, as 
numbers of NK cells remained lower than wild type controls at day 5 post-infection. NK cells were 
also less activated in Flt3L KO mice, as demonstrated by their failure to upregulate expression 
KLRG1, the transcription factor T-bet and the production of the cytokine IFN-!, all markers of 
effector function (Figure 2.5b). Collectively, these results suggest that NK cell responses are 
impaired in Flt3L KO mice.   
 
Analysis of CD4+ and CD8+ T cell responses  
Because DCs and their production of IL-12 are required for the induction of CD4+ and CD8+ T cell 
responses and long term resistance to toxoplasmosis, the  CD4+ and CD8+ T cell responses to T. 
gondii in Flt3L KO mice were assessed.  To identify polyclonal CD4+ and CD8+ T cell responses 
the combination of the activation marker CD11a and the marker of cellular proliferation Ki67 were 
utilized (McDermott and Varga, 2011; Rai et al., 2009; Scholzen and Gerdes, 2000). Additionally, 
because mice were infected with a strain of T. gondii engineered to secrete Ovalbumin (OVA),  
CD11a was combined with MHCI tetramers that bind to CD8+ T cells specific for the T. gondii 
epitope Tgd_057, and MHCI tetramers that bind to CD8+ T cells specific for OVA. Although at day 
8 post-infection, decreased percentages and numbers of polyclonal activated CD4+ and CD8+ T 
cells were apparent in the spleens of Flt3L KO mice, expansion of CD4+ and CD8+ T cells did 
occur in Flt3L KO mice (Figure 2.6a,b).  Similarly, a defect in numbers of OVA-specific CD8+ T 
cells was apparent, although infection induced an increase in OVA-specific CD8+ T cells in Flt3L 
KO mice (data not shown).  Since production of IFN-! from CD4+ and CD8+ T cells is critical for 
immunity to T. gondii, IFN-! production from CD4+ and CD8+ T cells was examined.  Both CD4+ 
and CD8+ T cells from Flt3L KO mice displayed impaired production of IFN-! directly ex vivo 
(Figure 2.6c,d).  Stimulation of T cells with PMA and ionomycin also resulted in less IFN-! 
production from CD4+ and CD8+ T cells from Flt3L KO mice than was observed from wild type 
controls.  These results suggest that despite impaired numbers of DCs and decreased IL-12 
production, sufficient antigen presentation occurs during toxplasmosis in Flt3L KO mice to induce 
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T cell expansion, however deficient production of IFN-! from CD4+ and CD8+ T cells likely 
contributes to the inability to control parasite burden.   
Administration of exogenous IL-12 can rescue Flt3L KO mice    
Since susceptibility to toxoplasmosis in Flt3L KO mice was associated with decreased IL-12 
production, and because IL-12 is critical for survival during toxoplasmosis, IL-12 was 
administered to Flt3L KO mice to determine the effect this has on parasite burden.  Administration 
of exogenous IL-12 resulted in a dramatic decrease in parasite burden in Flt3L KO mice (Figure 
2.7a).  Although treatment with IL-12 did not increase IFN-! production from NK cells on a per-cell 
basis (Figure 2.7b), IL-12 treatment significantly increased the numbers of natural killer cells at 
the site of infection in Flt3L KO mice (Figure 2.7c).  This finding highlights the role of DCs as 
critical producers of IL-12 during toxoplasmosis. 
 
Discussion 
 Previous studies have observed an infection-induced expansion of DCs during 
toxoplasmosis, and identified DCs as major sources of IL-12 critical for controlling infection 
(Goldszmid et al., 2009; Hou et al., 2011; Mashayekhi et al., 2011; Pepper et al., 2008; Scanga et 
al., 2002; Tait et al., 2010). However, questions remained regarding the underlying mechanisms 
that lead to the expansion of DCs, and the Flt3/Flt3L interaction represented one candidate that 
might contribute to DC expansion and homeostasis during this infection. Herein, mice deficient in 
Flt3L were found to be acutely susceptible to infection with T. gondii.  Infection with T. gondii 
resulted in an increase in numbers of DCs in the spleen and at the site of infection in both WT 
and Flt3L KO mice, and the DCs from the PECS of Flt3L KO mice displayed defective IL-12 
production on a per-cell basis.  This defect could potentially result from a role for Flt3L in 
promoting IL-12 production from DCs, as Flt3L has previously been shown to promote IL-12 
production (Eidenschenk et al., 2010; Vollstedt et al., 2004). Alternatively, this lack of IL-12 could 
be a consequence of the defective production of IFN-! from NK cells, which is necessary for 
optimal production of IL-12 at the site of infection (Goldszmid et al., 2012). In addition to the 
impaired production of IL-12 on a per-cell basis, Flt3L KO mice also have reduced numbers of 
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DCs, which likely contributes to the decreased systemic levels of IL-12 observed during 
toxoplasmosis in these mice. The administration of exogenous IL-12 resulted in decreased 
parasite burdens in Flt3L KO mice, thus highlighting the critical role of DCs as sources of IL-12, 
and pointing toward defective IL-12 production as the likely underlying cause of susceptibility in 
Flt3L KO mice.   
 The finding that CD4+ and CD8+ T cells expanded in response to infection in Flt3L KO 
mice was somewhat surprising, as previous studies have demonstrated a critical role for DCs in 
the induction of T cell responses (Tait et al., 2010). While the decreased production of IFN-! may 
result from the defect in IL-12 levels, the expansion of CD4+ and CD8+ T cells indicates that Flt3L-
independent populations are sufficient to present antigen. This could be mediated by the DCs that 
exist in the absence of Flt3L, other populations of professional antigen presenting cells (such as 
macrophages or B cells), or non-hematopoietic cells (Dzierszinski et al., 2007). 
 The defect in NK cell responses observed in these studies likely results primarily from the 
lack of IL-12 production, as KLRG1, T-bet and IFN-! are all induced by IL-12 signaling (Wilson et 
al., 2010), and treatment with IL-12 resulted in control of infection and increased numbers of IFN-
!-producing NK cells at the site of infection. Previous studies have identified DCs as an important 
source of IL-15, a cytokine that promotes the survival of NK cells (Ranson et al., 2003), and 
decreased levels of IL-15 have been implicated as the cause of the decreased numbers of NK 
cells present in Flt3L KO mice (Guimond et al., 2010). However, infection of IL-15 KO mice with 
T. gondii induces an expansion of NK cells to the levels present in infected WT mice, thus 
deficiency in IL-15 is an unlikely explanation for the defective NK cell responses observed in Flt3L 
KO mice during toxoplasmosis (Lieberman et al., 2004). Flt3L has also been demonstrated to 
enable the DC-mediated activation of NK cells in response to MCMV, and a similar role for Flt3L 
during toxoplasmosis cannot be ruled out (Eidenschenk et al., 2010). It is also notable that IL-12 
treatment did not completely restore IFN-! production from NK cells in Flt3L KO mice to the levels 
observed in WT mice, suggesting the possibility of other IL-12 independent roles for DCs in 
immunity to T. gondii.  However, these data may be confounded by differences in parasite burden 
between WT and IL-12-treated Flt3L KO mice. 
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 Although several studies have observed an infection-induced increase in numbers of DCs 
during toxoplasmosis (Mashayekhi et al., 2011; Tait et al., 2010), the mechanisms that mediate 
this process remain unknown. The increased numbers of CD11bHI DCs observed in this study 
and previous reports could be accounted for by the maturation of inflammatory monocytes into 
mature CD11bHI DCs (Leon et al., 2007). Indeed, monocyte-derived DCs have been reported to 
develop independently of Flt3 (Karsunky et al., 2003), and this is consistent with the finding that 
DC numbers increase in Flt3L KO mice. However, inflammatory monocytes are not thought to 
give rise to CD11bLOW DCs or CD8"+ DCs (Dominguez and Ardavin, 2010; Leon et al., 2007), 
raising the question of how these populations increase in number in Flt3L KO mice. Increased 
proliferation of mature DCs or their precursors, as well as increased differentiation of DC 
precursors represent additional pathways by which DC populations might increase in size. Since 
all of these pathways are promoted by Flt3L (Watowich and Liu, 2010), it was not expected that 
DC numbers would increase in the absence of this cytokine. Granulocyte-macrophage stimulating 
colony factor (GM-CSF) is another cytokine that can promote dendritic cell development (Vremec 
et al., 1997), which may be responsible for the increase in numbers of DCs during infection. It is 
also possible that Flt3L and GM-CSF share redundant roles in the expansion of DC populations 
during infection.  Additionally, a recent report demonstrated that IL-12 can drive expression of the 
transcription factors Batf and Batf2, which can promote the development of CD8"+ DCs during 
infection in Batf3-deficient mice (Tussiwand et al., 2012), and this alternative pathway for 
dendritic cell development may contribute to the infection-induced expansion that occurs in wild 
type mice as well.  Identifying the mechanisms that drive this infection-induced increase could 
allow its physiological significance to be interrogated.  
 While the critical role for DCs in resistance to acute toxoplasmosis has been well 
established, their role during toxoplasmic encephalitis is less clear, although they have been 
observed in the brain during chronic infection (John et al., 2011). Many studies have focused on 
the critical role of DCs as sources of IL-12, and questions remain regarding the extent to which 
IL-12 is critical during chronic infection as well.  Whereas neutralization of IL-12 has no effect 
during chronic infection (Gazzinelli et al., 1994), sustained treatment with exogenous IL-12 is 
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required during chronic infection to control toxoplasmosis in IL-12-deficient mice (Yap et al., 
2000). Extending the survival of Flt3L KO mice by treating them with IL-12 early during infection 
may allow the role of DCs during chronic infection to be interrogated, and studies are currently 
underway to determine if Flt3L-independent populations are sufficient to provide long-term 
resistance. 
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Figure 2.1.  Expression of Flt3L and Flt3 during toxoplasmosis.  C57BL/6 mice were infected 
with 103 tachyzoites and immune responses were analyzed 5 days post-infection.  A.  Levels of 
Flt3L from the serum of infected and naïve mice, measured by ELISA.  B.  Expression of Flt3 on 
DCs (CD3-veCD19-veNK1.1-veCD11cHIMHCIIHI), macrophages (CD3-veCD19-veNK1.1-veCD11cLOW-
INTLy6c-veLy6g-veCD11bHI), monocytes (CD3-veCD19-veNK1.1-veCD11cLOW-INTLy6c+ve) and 
neutrophils (CD3-veCD19-veNK1.1-veCD11cLOW-INTLy6g+ve) in naïve and infected mice.  Flow plots 
on the left display the gating strategy for DCs, and the flow plots are gated on CD3-veCD19-
veNK1.1-ve cells.  C. Expression of CD11b on Flt3HI and Flt3LOW DCs.  The geometric mean 
fluorescence intensity (MFI) of CD11b expression of the  Flt3HI and Flt3LOW DC populations 
depicted in B are shown.  D. Effects of infection on expression of Flt3.  Histograms on the left 
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display Flt3 expression levels on peritoneal DC populations, and are gated on CD3-veCD19-
veNK1.1-veCD11cHIMHCIIHI cells.  Graph on the right displays the MFI of Flt3 expression on Flt3HI 
and Flt3LOW populations in naïve (black bars) and infected (white bars) mice.  E. Numbers of 
Flt3HI DCs in the PECS of naïve and infected mice. 
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Figure 2.2.  Impaired ability to control toxoplasmosis in Flt3L KO mice. A. Survival of Flt3L 
KO and WT mice following challenge with 103 tachyzoites.  B. Infection rates were determined in 
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the peritoneal cavity (by cytospin analysis) and in the spleen (by flow cytometry) eight days 
following infection.  C. Histological examination of liver tissue revealed numerous sites of extra-
medullary hematopoiesis in infected wild-type (top left), but not Flt3L KO mice (top right). Sites of 
extra-medullary hematopoiesis from WT mice are shown (bottom left and right).  Differences are 
quantified (bar graph). 
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Figure 2.3:  Dendritic cell responses at the site of infection in Flt3L KO mice.  Mice were 
infected with 103 tachyzoites and peritoneal dendritic cell responses were analyzed 5 days post-
infection. A.  Numbers and percentages of DCs at the site of infection in WT and Flt3L KO mice. 
Flow plots are gated on CD3-veNK1.1-veCD19-ve cells.  B.  Production of IL-12p40 in WT mice by 
DCs (CD3-veCD19-veNK1.1-veCD11cHIMHCIIHI), macrophages/monocytes (CD3-veCD19-veNK1.1-
!
"#$%"!&
$#'%"!&
(#)%"!&
'#!%"!&
*+
,-
./
010
23
2,
445$#!N &#"!#('( "#NN
6+""2
7
8
6
99
:
;<3= ;<39=>?@3= ?@39=>
9AB"$
C
C
6
B:
;<3= ;<39=>?@3= ?@39=>
D
9A
B"
$E
$$#" !#&!( "#((
9AB"$
C
C
6
B:
+,-./010232,445 =,F1/GHI045
7J2/GHIJK,5L
7G-G2M1,5
!#!
"$#'
$'#!
(N#'
'!#!
D
9A
B"
$E
+6
5
=,
F1/
GH
I04
5
7J
2/G
HI
JK
,5
L
7G
-G
2M
1,5
B
C
!
"!
$!
(!
&!
;
<3=
?@
3=
;
<39
=>
?@
39=
>
**
*****
*
("!#)N' $#"( "#"P
;
<3=
?@
3=
;
<39
=>
?@
39=
>
6+""O89 6+""OA@;
!
"!
$!
(!
&!
D
9A
B"
$E
9AB"$
6
+
""
O
+,-./010232,445
D
*
Q#"Q
($#Q
C
C
6
B:
6+""O893+65
6+""OA@;3+65
!
!
52 
veCD11cLOW-INTLy6g-veCD11bINT-HI), neutrophils (CD3-veCD19-veNK1.1-veCD11cLOW-INTLy6g+ve).  IL-
12p40 production was measured by incubating PECS in the presence of BFA for 6 hours and 
staining for IL-12p40 by ICS. C. Production of IL-12p40 from peritoneal DCs of infected WT and 
Flt3L KO mice.  IL-12 production was assayed as in B.  D.  IL-12 production from various DC 
subsets in the PECS of WT mice at day 5 post-infection.  Gating strategy for CD11bHI and 
CD11bLOW DCs is shown (left).  Flow plot is gated on CD3-veCD19-veNK1.1-veCD11cHIMHCIIHI 
cells. IL-12 production from CD11bHI (middle, top) and CD11bLOW DC (middle, bottom) 
populations are shown and quantified (right). 
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Figure 2.4.  Expansion of splenic DC populations in WT and Flt3L KO mice.  Splenic DC 
populations analyzed 8 days post-infection with 103 tachyzoites.  A.  Percentages and numbers of 
splenic DCs.  Flow plots are gated on CD3-veCD19-veNK1.1-ve cells.  Numbers of splenic DCs are 
quantified.  B.  The composition of DC populations in naïve and infected WT and Flt3L KO mice is 
shown.  Flow plots are gated on CD3-veCD19-veNK1.1-veCD11cHIMHCIIHI cells. 
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Figure 2.5.  Natural killer cell responses in WT and Flt3L KO mice.  Natural killer cell 
responses were examined 5 days post-infection with 103 tachyzoites.  A.  Numbers and 
percentages of NK cells in the PECS are shown.  Similar trends were apparent in the spleen.  
Flow plots are gated on CD3-ve cells.  B.  Expression of T-bet, KLRG1 and IFN-! on splenic NK 
cells is shown. 
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Figure 2.6.  CD4+ and CD8+ T cell responses to T. gondii in WT and Flt3L KO mice.  WT and 
Flt3L KO mice were infected with 103 tachyzoites and CD4+ and CD8+ T cell responses were 
examined 8 days post-infection.  A,B. Splenic CD4+ (A) and CD8+ (B) T cell responses were 
measured using expression of CD11a and Ki67.  Flow plots are gated on CD3+CD4+ (A) or 
CD3+CD8+ (B) T cells. C,D. Spleenocytes were incubated for 4 hours with Brefeldin A, in the 
presence or absence of PMA and ionomycin.  IFN-! production was measured from the CD4+ (C) 
and CD8+ (D) T cells by flow cytometry.  Flow plots are gated on CD3+CD4+ (C) or CD3+CD8+ (D) 
T cells. 
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Figure 2.7.  IL-12 treatment can decrease parasite burden and partially restore natural killer 
cell responses in Flt3L KO mice.  Flt3L KO mice or WT mice were infected with 103 tachyzoites 
and IL-12 was administered on days 0-3 post-infection for experiments with an endpoint of day 5 
post-infection, and days 0-3,5 and 7 for experiments with an endpoint of day 8 post-infection.  A.  
Parasite burden in the peritoneal cavity at days 5 and 8 post infection, as measured by flow 
cytometry using fluorescently-labeled parasites, or by cytospin analysis.  B.  IFN-! production 
from peritoneal NK cells in WT and Flt3L KO mice, with or without treatment with exogenous IL-
12.  Flow plots are gated on CD3-veNKp46+ve cells.  Percentages of IFN-!+ve cells and the MFI of 
the IFN-!+ve population are shown.  C.  Quantification of natural killer cells in the PECS of WT and 
Flt3L KO mice.  Flow plots are gated on live cells, and granulocytes and macrophages have been 
excluded by forward and side scatter.      
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CHAPTER 3: PARASITE FATE AND EARLY EVENTS INVOLVED IN THE GENERATION OF 
CD4+ AND CD8+ T CELL RESPONSES 
 
Abstract 
 During infection with the intracellular parasite Toxoplasma gondii, the presentation of 
parasite-derived antigens to CD4+ and CD8+ T cells is essential for long-term resistance to this 
pathogen. Fundamental questions remain regarding the roles of phagocytosis and active invasion 
in the events that lead to the processing and presentation of parasite antigens. To understand the 
most proximal events in this process, an attenuated non-replicating strain of T. gondii (the cpsII 
strain) was combined with a flow cytometry-based approach to distinguish active invasion from 
phagocytic uptake. In vivo studies revealed that T. gondii preferentially infected dendritic cells, 
and infected dendritic cells displayed an activated phenotype characterized by enhanced levels of 
CD86 compared to cells that had phagocytosed the parasite, thus suggesting a role for infected 
dendritic cells in priming naïve T cells. Indeed, dendritic cells were required for optimal CD4+ and 
CD8+ T cell responses, and the phagocytosis of heat-killed or invasion-blocked parasites was not 
sufficient to induce T cell responses. Rather, the selective transfer of cpsII-infected dendritic cells 
to naïve mice potently induced CD4+ and CD8+ T cell responses, and conferred protection 
against challenge with virulent T. gondii. Collectively, these results point toward a critical role for 
actively infected host cells in initiating T. gondii-specific CD4+ and CD8+ T cell responses. 
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Introduction 
 As described in Chapter 1 of this thesis, successful control of infection with Toxoplasma 
gondii requires a rapid TH1 immune response, characterized by the production of the cytokine IL-
12, which promotes the ability of parasite-specific CD4+ and CD8+ T cells to produce the cytokine 
Interferon-! (IFN-!) (Gazzinelli et al., 1992a; Gazzinelli et al., 1994; Suzuki et al., 1988). The 
initiation of CD8+ T cell responses is a complex process which requires that professional antigen 
presenting cells acquire antigens and present them in the context of Major Histocompatibility 
Complex (MHC) I, and multiple models have been proposed to explain how this may occur during 
toxoplasmosis (Dupont et al., 2012; Goldszmid and Sher, 2010). For example, in other systems, 
foreign antigens are acquired through the pinocytosis of soluble antigens, the phagocytosis of 
large particulate antigens, or the phagocytosis of host cells containing foreign antigens, and 
subsequently presented to CD8+ T cells through cross-presentation (Brode and Macary, 2004; 
Steinman et al., 2003). A role for cross presentation during toxoplasmosis is supported by in vivo 
imaging studies showing that uninfected dendritic cells interact extensively with parasite-specific 
CD8+ T cells (Chtanova et al., 2009; Goldszmid and Sher, 2010; John et al., 2009). Alternatively, 
since T. gondii is an intracellular parasite, actively infected dendritic cells may acquire parasite-
derived antigens from their intracellular environment independently of phagocytosis and directly 
prime naïve CD8+ T cells. Indeed, the ability of cells actively infected by T. gondii to prime or 
present antigen to CD8+ T cells has been observed in vitro (Dzierszinski et al., 2007; Goldszmid 
et al., 2009; Gubbels et al., 2005) and the critical role of perforin in immunity to T. gondii 
implicates the cytolysis of infected host cells as a mechanism of defense, thus arguing that 
infected cells can present antigen to effector CD8+ T cells in vivo (Denkers et al., 1997). However, 
several caveats must be acknowledged in interpreting these studies. Firstly, the ability of infected 
cells to present antigens to reporter cells lines or activated effector CD8+ T cells does not 
necessarily indicate that infected cells can prime naïve CD8+ T cells, and events that occur in 
vitro may not represent the in vivo situation. Additionally, it can be difficult to distinguish actively 
infected host cells from cells that have phagocytosed the parasite by flow cytometry, thus 
confounding experimental interpretation. Furthermore, like many intracellular pathogens, T. gondii 
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has been reported to inhibit the expression or upregulation of molecules involved in antigen 
presentation such as MHCI, CD40, CD80, and CD86 in infected cells, suggesting that the ability 
of the ability of infected cells to prime naïve CD8+ T cells may be compromised (Luder et al., 
1998; Luder et al., 2001; McKee et al., 2004). 
 Antigens presented to CD4+ T cells in the context of MHCII may also be derived from the 
extracellular or intracellular environment of the host cell. Endocytosed antigens can be presented 
in the context of MHCII, and this pathway is considered to be the primary mechanism by which 
antigens are acquired for presentation to CD4+ T cells (Neefjes et al., 2011). However, 
intracellular antigens can also be presented in the context of MHCII, as cytosolic peptides are 
presented in the context of MHCII by B cells and macrophages (Dongre et al., 2001). Similarly, in 
vitro studies have demonstrated that viral or model antigens expressed intracellularly can be 
presented to CD4+ T cells independently of phagocytosis (Aichinger et al., 1997; Bonifaz et al., 
1999; Jaraquemada et al., 1990; Lich et al., 2000; Malnati et al., 1992; Nimmerjahn et al., 2003; 
Nuchtern et al., 1990; Paludan et al., 2005; Weiss and Bogen, 1991). Despite these findings, the 
role of infected cells in presenting antigen to CD4+ T cells in vivo during any infection remains 
unclear (Iwasaki and Medzhitov, 2010). In the case of T. gondii, downregulated expression of 
MHCII and other molecules involved in antigen presentation has been observed on infected cells, 
and cells infected with T. gondii exhibit decreased ability to present antigen in vitro (Luder et al., 
1998; Luder et al., 2001; McKee et al., 2004). Furthermore, in vitro studies have observed that 
antigens from heat-killed or invasion-inhibited parasites incubated with dendritic cells can be 
presented in the context of MHCII, consistent with a role for phagocytosis-dependent antigen 
presentation to CD4+ T cells (Goldszmid et al., 2009).  
 There are several difficulties involved with addressing the relative contributions of 
phagocytosis versus active invasion to antigen presentation in vivo during many infections. For 
example, interfering with these pathways can result in changes in pathogen burden and 
inflammation that confound experimental interpretation, and the parasite-mediated lysis of host 
cells and re-infection may obscure the analysis of the earliest cell populations that interact with 
the pathogen. In addition, there are limited tools to distinguish host cells that have phagocytosed 
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pathogens from those that have been productively infected. In the present study, these issues are 
addressed using a non-replicating uracil auxotrophic vaccine strain of T. gondii (the cpsII strain) 
(Fox and Bzik, 2002; Wilson et al., 2010; Wilson et al., 2008) and a novel assay that tracks the 
fate of parasites and distinguishes active invasion from phagocytosis in vivo. Using these 
approaches, cpsII parasites were found to infect large numbers of macrophages and to 
preferentially infect dendritic cells, and dendritic cells were found to be necessary for optimal 
cpsII-induced CD4+ and CD8+ T cell responses. Infected dendritic cells displayed an activated 
phenotype, characterized by high levels of CD86 and MHCI expression, which was unique from 
the phenotype of dendritic cells that had phagocytosed T. gondii. Furthermore, the administration 
of heat-killed or invasion blocked parasites did not induce CD4+ or CD8+ T cell responses, thus 
demonstrating that phagocytosis of parasites is insufficient to activate naïve T cells. Lastly, the 
selective transfer of infected dendritic cells to naïve mice resulted in robust CD4+ and CD8+ T cell 
responses and protection from challenge with a virulent strain of T. gondii. These findings point 
toward a critical role for infected cells in initiating the adaptive immune response to T. gondii. 
 
Materials and Methods 
Ethics Statement All procedures involving mice were reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of Pennsylvania (Animal Welfare Assurance 
Reference Number #A3079-01) and were in accordance with the guidelines set forth in the Guide 
for the Care and Use of Laboratory Animals of the National Institute of Health. 
Mice Flt3L KO mice were obtained from Taconic Farms (Germantown, NY). Batf3 KO mice and 
CD11c-DTR mice were obtained from Jackson Laboratories. C57BL/6 mice were obtained from 
Jackson Laboratories or Taconic Farms. All mice were kept in specific-pathogen-free conditions 
at the School of Veterinary Medicine at the University of Pennsylvania. For experiments in which 
dendritic cells were depleted, CD11c-DTR or WT control mice were administered 100 ng of 
Diphtheria Toxin (Sigma-Aldrich) diluted in 100 µL of PBS (Invitrogen) intraperitoneally ~12 hours 
prior to vaccination. Depletion efficiency was typically 90%.  
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Infections All experiments were performed using cpsII parasites, cpsII-OVA parasites (Jordan et 
al., 2009), cpsII-OVA-mCherry parasites, or RH-OVA-Tomato parasites. RH-OVA-Tomato 
parasites (Whitmarsh et al., 2011) and cpsII-OVA parasites (Jordan et al., 2009; Pepper et al., 
2004) have been previously described, and cpsII-OVA parasites were derived from the RH$cpsII 
clone, which was provided as a generous gift by Dr. David Bzik (Fox and Bzik, 2002). CpsII-OVA-
mCherry parasites were derived from the cpsII-OVA clone using the previously described 
methods (Koshy et al., 2012; Koshy et al., 2010), with the exception that parasites were selected 
using zeomycin as previously described (Messina et al., 1995). Parasites were cultured and 
maintained by serial passage on human foreskin fibroblast cells in the presence of parasite 
culture media [71.7% DMEM (Corning), 17.9% Medium 199 (Invitrogen), 9.9% Fetal Bovine 
Serum (FBS)(Invitrogen), 0.45% Penicillin and Streptomycin (Invitrogen)(final concentration of 
0.05 units/ml Penicillin and 50 µg/ml Streptomycin), 0.04% Gentamycin (Invitrogen)(final 
concentration of 0.02 mg/ml Gentamycin)], which was supplemented with uracil (Sigma-
Aldrich)(final concentration of 0.2 mM uracil) in the case of cpsII, cpsII-OVA and cpsII-OVA-
mCherry parasites. For infections, parasites were harvested and serially passaged through 18, 20 
and 26 gauge needles (BD) before filtration with a 5 µM filter (Sartorius Stedim). Parasites were 
washed extensively with PBS and mice were injected intraperitoneally with 105 or 106 parasites 
suspended in PBS. In vitro experiments were performed at an MOI of 0.5 or 1. For experiments in 
which CellTraceTM Violet (Invitrogen) was utilized to track the fate of parasites, CellTraceTM Violet 
was diluted in 200 µL of DMSO to obtain a 0.5 mM stock solution. Parasites were washed once 
with PBS before incubation in 0.5 µM CellTraceTM Violet diluted in PBS for 10-25 minutes at 37O 
C. This reaction was quenched by the addition of ~40 volumes of complete media [88.5% RPMI 
1640 (Corning), 8.8% FBS (Invitrogen), 0.9% Sodium Pyruvate (Gibco), 0.9% Penicillin and 
Streptomycin (Invitrogen)(final concentration of 0.1 units/ml Penicillin and 100 µg/ml 
Streptomycin), 0.9% MEM Non-essential Amino Acids Solution (Gibco) and 0.18% beta-2-
mercaptoethanol (Gibco)] and parasites were washed extensively. In experiments in which 4-p-
bromophenacyl bromide (4-p-bpb) was utilized to inhibit parasite invasion, 4-p-bpb (Sigma-
Aldrich) was prepared fresh for each experiment and dissolved in DMSO (Sigma-Aldrich) to make 
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a 0.1 M stock solution. Parasites were incubated in a 100 µM solution of 4-p-bpb in Fetal Bovine 
Serum at a concentration of 107 parasites/ml for 10 minutes, and the reaction was quenched by 
the addition of ~40 volumes of complete media, followed by extensive washing (Goldszmid et al., 
2009). To heat-kill parasites, parasites were incubated at 60OC for 1 hour in PBS (Haque et al., 
1999). Death was confirmed using Trypan Blue staining (Corning). 
Cell culture and tissue harvesting Peritoneal exudate cells were obtained by peritoneal lavage 
with 5 ml of PBS. Splenocytes and lymphocytes were obtained by grinding spleens and lymph 
nodes over a 40 µM filter (Biologix) and washing them in complete media. Red blood cells were 
then lysed by incubating for 5 minutes at room temperature in 5 ml of lysis buffer [0.864% 
ammonium chloride (Sigma-Aldrich) diluted in sterile de-ionized H2O)], followed by washing with 
complete media. Bone marrow-derived macrophages were obtained using previously described 
methods (Robben et al., 2004; Whitmarsh et al., 2011). Immortalized macrophages from C57BL/6 
mice were obtained by transforming bone marrow derived macrophages with the J2 Virus and 
were cultured in macrophage media (Blasi et al., 1989).  
Flow Cytometry and imaging Tetramer-specific CD4+ T cells were measured using the protocol 
previously described (Pepper et al., 2011). MHCII Tetramer was obtained as generous gifts from 
Drs. Marc Jenkins and Marion Pepper, and subsequently from the NIH Tetramer Core Facility, 
and was used at a final concentration of 10 nM. APC-MHCI-SIINFEKL Tetramer was obtained 
from Beckman-Coulter. Cells were washed with FACS Buffer [1x PBS, 0.2% bovine serum 
antigen (Sigma), 1 mM EDTA (Invitrogen)], stained with LIVE/DEAD® Fixable Aqua Dead Cell 
marker (Invitrogen) and incubated in Fc block [99.5% FACS Buffer, 0.5% normal rat serum 
(Invitrogen), 1 µg/ml 2.4G2 (BD)] prior to staining. The following antibodies were used for 
staining: Ki67 Alexa Fluor®488 (BD, B56), CD3 APC-eFluor®780 (eBioscience, 17A2), CD8 
eFluor®450 (eBioscience, 53-6.7), CD11a PerCP-Cy5.5 (Biolegend, H155-78), MHCII PE 
(eBioscience, M5/114.15.2), NK1.1 PE (BD, PK136), CD19 PE (eBioscience, 1D3), Foxp3 
eFluor®450 (eBioscience, FJK-16a), CD4 Pe-Cy7 (eBioscience, GK1.5), CD3 FITC (BD, 145-
2C11), NK1.1 FITC (eBioscience, PK136), CD19 FITC (eBioscience, 1D3), Gr-1 PerCP-Cy5.5 
(eBioscience, RB6-8C5), CD11c PE-Cy7 (eBioscience, N418), CD11b APC-eFluor®780 
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(eBioscience, M1/70), MHCII AF700 (Biolegend, M5/114.15.2), MHCI APC (AlexaFluor®647 AF6-
88.5), CD86 APC (eBioscience, GL1), CD40 APC (eBioscience 1C10), CD8 eFluor®650 NC 
(eBioscience, 53-6.7), CD45.2 APC-eFluor®780 (eBioscience, 104), polyclonal rabbit anti-T. 
gondii [a generous gift from Fausto G. Araujo (Palo Alto Medical Foundation, Palo Alto, CA)], and 
polyclonal Goat anti-Rabbit Alexa Fluor® 680 (Jackson). Intracellular staining was performed 
using the Foxp3/ Transcription Factor Staining Buffer Set (eBioscience) following the 
manufacturer’s instructions. Samples were run on a FACSCanto (BD) or LSR Fortessa (BD) and 
analyzed using FlowJo Software (TreeStar). Images were obtained using the ImageStream and 
analysis was performed using IDEAS software (Amnis). 
Sorting Splenic dendritic cells were obtained from mice injected subcutaneously with Flt3L-
secreting b16 tumor cells (Curran and Allison, 2009; Maraskovsky et al., 1997) and magnetically 
enriched using CD11c microbeads (Miltenyi Biotech) and LD MACS® separation columns 
(Miltenyi Biotech), following the manufacturer’s instructions. Following enrichment, dendritic cells 
were cultured overnight with parasites at 37O C and collected the following day. Dendritic cells 
were then stained for MHCII, CD11c, CD45, and free parasites, and sorted for 
mCherry+veViolet+ve or   mCherry-veViolet-ve populations that were CD45+MHCIIHICD11cHI, and 
negative for free parasites using the FACSAria (BD).  
Electron microscopy  Bone marrow derived macrophages from C57BL/6 mice were activated 
with IFN-! and LPS for 18-24 hours or left untreated in macrophage media lacking uracil [DMEM 
(Gibco) supplemented with 4mM L-glutamine (Sigma) and 10% dialyzed fetal bovine serum 
(Hyclone)]. Where indicated, cells were infected with freshly egressed parasites, washed three 
times with PBS then fixed at 2 hours or 24 hours post infection. For ultrastructural analysis, cells 
were fixed in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 
100 mM phosphate buffer, pH 7.2 for 1 hour at room temperature, processed and examined as 
described previously (Fentress et al., 2010). 
Immunofluorescence assays  Immunofluorescence assays were performed in RAW 264.7 
macrophages. Cells were activated as indicated with IFN-! and LPS for 18-24 hours in 
macrophage media lacking uracil. Macrophages were infected with freshly egressed parasites at 
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an MOI of 1, washed at 30 minutes post infection three times with PBS, and incubated in uracil-
free media for the indicated time. Cells for immunofluorescence were fixed in 4% formaldehyde, 
permeabilized with 0.05% saponin, and stained using primary antibodies as described. Parasite 
vacuoles were localized using mouse monoclonal Tg17-43 against GRA1 or rabbit polyclonal 
sera against GRA7. Host LAMP-1 was localized with rat monoclonal antibody 1D4B and Irgb6 
was localized using rabbit polyclonal sera raised against recombinant protein (Henry et al., 2009). 
All secondary antibodies used in immunofluorescence were highly-cross adsorbed Alexa Fluor 
conjugated antibodies (Invitrogen). Samples were visualized using a Zeiss Axioskop 2 MOT Plus 
microscope equipped for epifluorescence and using a 63X Plan Apochromat lens, N.A. 1.40 (Carl 
Zeiss, Inc., Thornwood, NY). Images were acquired with an AxioCam MRm camera (Carl Zeiss, 
Inc.) using Axiovision v4.6, and processed using similar linear adjustments for all samples in 
Photoshop CS4 v9.  
Statistical Analysis  Statistical analysis was performed using PRISM software (Graphpad 
Software). Significance was calculated using an unpaired two-tailed student’s t-test except when 
otherwise noted.  
 
Results 
Development of a system to distinguish phagocytosis of parasites from active invasion  
 To distinguish between parasites that are phagocytosed by host cells and those that 
actively infect host cells, differences in sensitivity to pH between the fluorescent markers mCherry 
and CellTraceTM Violet were exploited. When mCherry-expressing parasites were labeled 
intracellularly with CellTraceTM Violet and incubated overnight in buffer solutions of varying pH, 
mCherry fluorescence was retained (Figure 3.1a). In contrast, violet fluorescence intensity was 
maintained at pH 7.0 but was decreased at low pH (Figure 3.1a). The ability of this system to 
distinguish active invasion from phagocytosis was demonstrated in vitro by incubating Violet-
labeled, mCherry-expressing cpsII parasites with macrophages and examining fluorescence by 
flow cytometry 1 hour and 18 hours post infection. At one hour after incubation with parasites, two 
distinct macrophage populations were present: One displayed mCherry and Violet fluorescence, 
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while the other was negative for both markers (Figure 3.1b). However, by 18 hours, two distinct 
mCherry+ve populations were apparent. One population displayed no loss of mCherry or Violet 
fluorescence (mCherry+veViolet+ve), while the other population had decreased mCherry 
fluorescence associated with a complete loss of violet fluorescence (mCherry+veViolet-ve). Utilizing 
ImageStream® flow cytometry to generate images of individual cells from each of these 
populations revealed that the mCherry+veViolet+ve cells contained intact parasites, while the 
mCherry+veViolet-ve cells contained dimmer and more diffuse mCherry fluorescence (Figure 3.1c, 
Figure 3.S1-3). Furthermore, pre-treatment of parasites with the irreversible inhibitor of invasion 
4-p-bromophenacyl bromide (4-p-bpb) (thus making parasites targets for phagocytosis) 
(Goldszmid et al., 2009; Morgado et al., 2011; Ravindran et al., 2009; Saffer et al., 1989), 
resulted in the complete loss of the mCherry+veViolet+ve population at 18 hours post-infection 
(Figure 3.1b,c, Figure 3.S1-3). Collectively, these results are consistent with a model in which 
phagocytosed parasites are degraded, and the acidic environment of the phagosome leads to a 
loss of Violet fluorescence, while mCherry fluorescence is retained. In contrast, when the parasite 
actively invades host cells and persists in the less acidic environment of the parasitophorous 
vacuole (PV), both Violet and mCherry fluorescence are retained.  
 The ability to distinguish active invasion from phagocytosis was then utilized to determine 
the fate of cpsII parasites in vivo. When C57Bl/6 mice were vaccinated intraperitoneally with 
Violet-labeled, mCherry-expressing parasites, mCherry+veViolet+ve and mCherry+veViolet-ve 
populations were apparent in the Peritoneal Exudate Cells (PECS) 18 hours post-vaccination, 
and the presence of the mCherry+veViolet+ve population was abrogated by pre-treating the 
parasites with 4-p-bpb (Figure 3.1d). Furthermore, when Violet+ve cells were sorted and cytospins 
examined, they were found to contain intact parasites (Figure 3.1e). ImageStream analysis also 
revealed that the mCherry+veViolet+ve population contained intact parasites whereas the 
mCherry+veViolet-ve population displayed diffuse mCherry fluorescence (Figure 3.1f, Figure 3.S4-
6). Collectively, these studies demonstrate that the use of fluorescent markers with differing pH 
sensitivities can be used to distinguish cells that have phagocytosed T. gondii from those that 
have been actively infected. 
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CpsII parasites persist in actively infected host cells 
Because many cpsII parasites were found to actively invade host cells, the fate of these parasites 
was then analyzed over time using electron microscopy and immunofluorescence assays to 
determine the integrity of the PV and the sub-cellular localization of the parasite. 
Immunofluorescence microscopy revealed that parasites can persist in infected cells up to forty-
eight hours following infection, in both macrophages activated with IFN-! and LPS, as well as 
untreated macrophages (Figure 3.2a,b). Because IFN-! can induce the recruitment of immune 
enzymes such as the Immunity Related Guanosine Triphosphatases (IRGs) to the PV, and these 
enzymes have been implicated in the rupture of the PV which leads to the xenophagic elimination 
of the parasite, the colocalization of the parasite with Irgb6 (a member of the IRG family) and 
LAMP-1 (which is expressed on lysosomes) was examined in macrophages pre-treated with IFN-
! and LPS. CpsII parasites were not found to colocalize with either Irgb6 or LAMP-1, arguing 
against a role for the IRG-mediated and xenophagic elimination of cpsII parasites, respectively 
(Figure 3.2a,b). Electron microscopy was also utilized to examine the integrity of the PV, since 
IFN-! can induce the blebbing and rupture of the PV during infection with replicating strains of T. 
gondii (Ling et al., 2006; Martens et al., 2005). Using electron microscopy, no IFN-! induced 
blebbing or rupture of the PV was apparent in cpsII-infected (Figure 3.2c). Additionally, some 
cpsII parasites showed atypical morphology, indicative of non-productive cell division (Figure 
3.2d). To measure the persistence of cpsII parasites in vivo, bioassays were performed in which 
tissues from vaccinated mice were cultured in the presence of exogenous uracil and examined by 
microscopy for the presence of cpsII parasites. Using this method, cpsII parasites were found to 
persist in the peritoneal cavity up to five days post-vaccination (data not shown). These results 
confirm that cpsII parasites cannot replicate within host cells, and suggest that cpsII parasites can 
persist for long periods of time, evading IFN-!-mediated destruction.  
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 Identification and phenotypic analysis of cells that are infected by or phagocytose cpsII 
parasites  
To better understand the fate of cpsII parasites in vivo, mice were challenged intraperitoneally 
with Violet-labeled, mCherry-expressing cpsII parasites, and flow cytometry was performed on 
the PECS 18 hours later to characterize the cell populations that had phagocytosed T. gondii or 
were actively infected. The largest population of mCherry+veViolet+ve cells to be infected was 
CD11bHI macrophages, which comprised 44±16.7% of infected cells. Dendritic cells (which have 
been previously implicated in the induction of T cell responses to cpsII (Gigley et al., 2009)) 
comprised 8.3±2.8% of infected cells (Figure 3.3a). Of the infected dendritic cells the vast 
majority (97.8±2%) belonged to the Gr-1-veCD11bHI subset (data not shown). Although T. gondii is 
capable of infecting any nucleated cell, dendritic cells were overrepresented in the infected 
population, suggesting that this population is preferentially infected by the parasite (Figure 3.3b). 
Analysis of the population that had phagocytosed T. gondii revealed 46.0±20.6% of these cells 
were CD11bHI macrophages, whereas dendritic cells represented 6.2±3.2% of this population 
(Figure 3.3a). Parasites were not detected in lymph nodes or spleens by flow cytometry, and 
parasites could not be cultured from these tissues at days 3,5 or 10 post-vaccination (data not 
shown).  
 The phenotype of infected cells and cells that phagocytosed the parasite was compared 
by analyzing expression levels of MHCI and MHCII, as well as the costimulatory molecules CD86 
and CD40.  Although vaccination with cpsII resulted in an overall increase in expression of MHCI 
on CD11bHI macrophages, macrophages that had phagocytosed the parasite and those that were 
infected displayed similar MHCI levels to the total population of macrophages in the PECS of 
vaccinated mice. In contrast, dendritic cells that had phagocytosed cpsII and those that were 
infected by the parasite displayed higher levels of MHCI relative to the total dendritic cell 
population in the peritoneal cavity (Figure 3.4a). Vaccination with cpsII induced no significant 
changes in MHCII expression of CD11bHI macrophages or dendritic cells on any population that 
was examined (Figure 3.4b). Expression of CD86 was markedly higher on macrophages and 
dendritic cell populations that were infected by the parasite, but not the populations that had 
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phagocytosed the parasite (Figure 3.4c). While vaccination induced increased CD40 expression 
on the total dendritic cell population, infected cells displayed similar expression levels to the total 
population, and those that phagocytosed the parasite exhibited the highest levels of expression 
(Figure 3.4d). Collectively, these results demonstrate that infected dendritic cells display an 
activated phenotype, characterized by the upregulation of MHCI and CD86, and expression of 
CD40 and MHCII, which is unique from the phenotype of cells that have phagocytosed T. gondii.  
 
Dendritic cells are critical for optimal cpsII-induced CD4+ and CD8+ T cell responses  
 Given the activated phenotypes of dendritic cells infected with cpsII and those that had 
phagocytosed the parasite, studies were performed to determine the role of dendritic cells in the 
development of CD4+ and CD8+ T cell responses to this strain. Mice that express the diphtheria 
toxin receptor under the control of the CD11c promoter (CD11c-DTR mice) were used to test the 
requirement for dendritic cells to prime T cells (Jung et al., 2002). In these experiments, CD11c-
DTR mice were treated with diphtheria toxin, which resulted in a 70-90% reduction in dendritic 
cells (Figure 3.5a). One day following the administration of diphtheria toxin, mice were challenged 
with a strain of cpsII engineered to express Ovalbumin (cpsII-OVA) (Jordan et al., 2009). At eight 
days following vaccination, CD4+ and CD8+ T cell responses were measured using MHCII 
tetramers which bind CD4+ T cells specific for the endogenous T. gondii epitope CD4Ag28m 
combined with magnetic enrichment for the tetramer+ve population (Grover et al., 2012; Pepper et 
al., 2011), and MHCI tetramers for OVA-specific CD8+ T cells. Additionally, the surface molecule 
CD11a, which is upregulated on antigen-experienced CD4+ and CD8+ T cells (McDermott and 
Varga, 2011; Rai et al., 2009), and the intracellular molecule Ki67, which is indicative of cellular 
proliferation (Scholzen and Gerdes, 2000) were used to measure the total CD4+ and CD8+ T cell 
responses to T. gondii. Indeed, vaccination with cpsII induced a two-fold increase in the 
frequency of CD11aHIKi67HI cells and an  increase in the number of CD11aHI CD4+ T cells specific 
for the CD4Ag28m epitope, but depletion of dendritic cells inhibited these responses (Figure 
3.5b). Similarly, cpsII vaccination induced an increase in CD11aHI Ki67HI and OVA-specific CD8+ 
T cells, however these responses were decreased in mice depleted of dendritic cells (Figure 
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3.5c). Furthermore, when Flt3L-deficient mice (which have global defects in numbers of dendritic 
cells (McKenna et al., 2000)) or Batf3-deficient mice (which have a defect in numbers of CD8a+ 
dendritic cells (Hildner et al., 2008)) were challenged with cpsII-OVA, both mice displayed marked 
defects in tetramer-specific and total CD4+ and CD8+ T cell responses (Figures 3.S7, 3.S8). 
Collectively, these results establish a role for dendritic cells in the generation of CD4+ and CD8+ T 
cell responses following cpsII vaccination. 
 
Infected dendritic cells are sufficient to generate CD4+ and CD8+ T cell responses  
To assess the contribution of phagocytosis to the generation of CD4+ and CD8+ T cell responses, 
mice were challenged with live cpsII-OVA parasites, heat-killed cpsII-OVA parasites, or parasites 
pre-treated with the irreversible inhibitor of invasion 4-p-bpb. As expected, vaccination with live 
parasites induced the tetramer+ve and tetramer-ve CD4+ T cell responses, however these 
responses were abrogated when parasites were killed or invasion was inhibited (Figure 3.6a). 
Similarly, CD11aHIKi67HI and OVA-specific CD8+ T cells were detected when mice were 
administered live, but not heat-killed or invasion-inhibited parasites (Figure 3.6b). Indeed, even 
when the dose of heat-killed parasites was increased to 107 parasites (100x the typical dose of 
live parasites), no CD4+ or CD8+ T cell responses could be detected (data not shown). 
Additionally, gp91 KO mice, which have a defect in cross-presenting antigens to CD8+ T cells 
(Savina et al., 2006), developed normal CD8+ T cell responses following cpsII-vaccination (data 
not shown). Collectively, these data indicate that phagocytosis of parasites is insufficient to 
induce CD4+ and CD8+ T cell responses, and point toward a critical role for infected cells in these 
processes. 
 To directly test whether actively infected host cells induce CD4+ and CD8+ T cell 
responses, splenic dendritic cells were infected with violet-labeled, mCherry-expressing cpsII 
parasites in vitro overnight, and FACS sorting was used to purify the uninfected (mCherry-veViolet-
ve) and infected cells (mCherry+veViolet+ve) cells from the same cultures, and each of these 
fractions was then administered to naïve mice. Consistent with the in vivo data, dendritic cells that 
phagocytosed T. gondii in vitro comprised a small percentage of the total population, and it was 
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not feasible to isolate this population by sorting. In mice administered uninfected dendritic cells 
there was no detectable increase in proliferating, antigen-experienced CD4+ or CD8+ T cells 
(Figure 3.7a,b). In contrast, mice administered cpsII-infected dendritic cells developed CD4+ and 
CD8+ T cell responses as determined by tetramer-binding as well as expression of Ki67 and 
CD11a. Furthermore, when recipients of infected or uninfected dendritic cells were challenged 3 
weeks later with a highly virulent strain of T. gondii only those mice administered cpsII-infected 
dendritic cells displayed a ~99% reduction in parasite burden (Figure 3.7c). Collectively, these 
results demonstrate a critical role for infected cells in the induction of protective CD4+ and CD8+ T 
cell responses. 
 
Discussion 
There are many fundamental questions about the mechanisms of antigen presentation that lead 
to the activation of CD4+ and CD8+ T cells during toxoplasmosis and multiple studies have 
addressed the ability of actively infected cells to present antigen (Dzierszinski et al., 2007; 
Goldszmid et al., 2009; Gubbels et al., 2005; Subauste and Wessendarp, 2000). The present 
work highlights that following challenge in vitro or in vivo with live parasites there are high rates of 
phagocytosis and conventional methods using parasites that express a single fluorescent reporter 
protein are not sufficient to determine how an individual cell has interacted with T. gondii. Rather, 
the ability to combine parasites that express a pH insensitive reporter such as mCherry protein 
with a pH sensitive dye and analysis by high throughput imaging and flow cytometry provide a 
unique opportunity to examine parasite fate and host cell phenotype. This combination of 
approaches should be broadly applicable to determining the fate of other intracellular fungal, 
bacterial and parasitic pathogens (da Silva et al., 2012; Dunn and Valdivia, 2010; Overstreet et 
al., 2008; Rohde et al., 2007; Romano et al., 2012; Seider et al., 2010; Shin and Roy, 2008). 
Regardless, the ability to distinguish these fates revealed that macrophages and dendritic cells 
infected by T. gondii have unique activation phenotypes when compared to those that have 
phagocytosed the parasite. Previous reports have indicated that infection with T. gondii inhibits 
the maturation of professional antigen presenting cells (Goldszmid and Sher, 2010; Lang et al., 
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2006; Luder et al., 1998; McKee et al., 2004) but the data presented here are more consistent 
with the idea that infection induces DC maturation (Baird et al., 2013; Morgado et al., 2011; 
Subauste et al., 1998; Subauste and Wessendarp, 2000; Walseng et al., 2010). 
 In current paradigms, the direct phagocytosis or endocytosis of soluble and particulate 
non-infectious antigens is the major pathway that allows antigens to be presented in the context 
of MHCII to CD4+ T cells (Neefjes et al., 2011). Similarly, phagocytosed antigens are thought to 
be presented to CD8+ T cells through the process of cross-presentation (Brode and Macary, 
2004). However, the studies using invasion-blocked or heat-killed parasites, and the studies in 
which infected or uninfected cells were transferred to mice demonstrate that active invasion, 
rather than phagocytosis is critical to induce T cell responses following cpsII vaccination. These 
data are therefore consistent with models in which infected cells either directly prime CD4+ T and 
CD8+ T cells, or are taken up by efferocytosis (i.e. the phagocytosis of apoptotic cells), leading to 
antigen presentation. Both of these models imply a mechanism by which infected cells can sense 
the parasite, either to upregulate the signals that promote antigen presentation or to induce 
apoptosis, and the finding that infected cells display an activated phenotype is consistent with the 
idea that infected cells directly sense the parasite. Indeed, Toll Like Receptor-dependent and 
independent pathways have been implicated in sensing T. gondii, but questions remain regarding 
which specific host-parasite interactions (e.g. phagocytosis, active invasion, endocytosis of 
soluble antigens) activate specific sensing mechanisms (Egan et al., 2009b; Morgado et al., 
2011; Pifer and Yarovinsky, 2011; Witola et al., 2011). It is also possible that the activated status 
of infected cells results from the activity of effector proteins secreted by the parasite, which may 
act independently of molecules traditionally thought of as host pattern recognition receptors 
(Hunter and Sibley, 2012). 
 Since T. gondii resides in a specialized non-fusogenic vacuole, it is unclear how parasite 
antigens may escape the PV for processing and presentation. One possibility is that parasite 
antigens are acquired for presentation from the intracellular environment through the xenophagic 
elimination of cpsII parasites. In support of this possibility, autophagic machinery has been 
implicated in the elimination of T. gondii (Ling et al., 2006; Zhao et al., 2009b; Zhao et al., 2008), 
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and antigen acquired through autophagy can be subsequently presented (Nimmerjahn et al., 
2003; Paludan et al., 2005; Romao et al., 2013). However, the lack of recruitment of Irgb6 and 
Atg5 to the PVs containing cpsII parasites argues against this idea. Antigens may also escape 
the PV through the fusion of the PV with the endoplasmic reticulum (Goldszmid et al., 2009), may 
be secreted into the cytoplasm during the invasion process (Koshy et al., 2010), or may leak out 
of the PV (Gubbels et al., 2005). More recent work has shown that T. gondii can secrete antigens 
into host cells without subsequently infecting these cells (Koshy et al., 2012). This population of 
injected-but-uninfected cells may also contribute to the host immune response, and the ability to 
track these abortive invasion events in vivo (Koshy et al., 2010), as well as the ability to divorce 
injection from infection through modulation of the parasite, may provide further insight into the 
pathways involved in antigen processing during cpsII vaccination. Regardless, the finding that 
phagocytosis is insufficient to induce antigen presentation in this system highlights the 
importance of alternative approaches to deliver antigens for vaccine design and 
immunotherapies, such as those that target antigens to the host cell cytosol (Moon et al., 2012). 
 Given the lack of overt inflammation observed during infection with cpsII parasites, the 
absence of parasite-driven cytolysis of host cells, and limited antigen load, it was somewhat 
surprising that relatively low numbers of parasites are able to generate strong protective CD4+ 
and CD8+ T cell responses, comparable to those seen during live infection (Jordan et al., 2009; 
Wilson et al., 2010). Indeed, increased antigenic burden is generally associated with increased T 
cell responses, and inflammatory signals can promote pathways involved in antigen presentation, 
T cell proliferation, and T cell survival (Curtsinger and Mescher, 2010; Dresch et al., 2012; van 
Heijst et al., 2009). While many studies have utilized models of murine infection to elucidate the 
factors involved in the generation of T cell responses and the formation of memory T cells, 
vaccination with cpsII parasites allows these processes to be studied in a setting in which overt 
inflammation is absent. Thus, the basic principles learned from studying this system may 
translate more easily to vaccine design, where inflammation should be limited as well.   
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Figure 3.1: Differences in pH sensitivity of two fluorescent markers can be used to 
distinguish parasites that have been phagocytosed from those that actively invade host 
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cells. Fluorescence intensity of mCherry-expressing cpsII parasites labeled with CellTraceTM 
Violet and incubated overnight at varying pH in buffer solutions consisting of citric acid and 
disodium phosphate (McIlvaine, 1921) was measured by flow cytometry (a). Violet and mCherry 
fluorescence of immortalized murine bone marrow-derived macrophages exposed to Violet-
labeled, mCherry-expressing cpsII parasites pre-treated with DMSO (top) or the irreversible 
inhibitor of invasion 4-p-bpb (bottom) 1 hour and 18 hours following exposure to parasites, 
measured by flow cytometry (b). Images of mCherry+veViolet+ve and mCherry+veViolet-ve bone 
marrow derived macrophages 18 hours following exposure to Violet-labeled, mCherry-expressing 
cpsII parasites pre-treated with 4-p-bpb or DMSO (c). Violet and mCherry fluorescence of cells 
isolated from the PECS of mice 18 hours post-administration of 106 DMSO-treated or 4-p-bpb-
treated parasites (d). Cytospin analysis was performed on Violet+ve cells isolated by FACS 
sorting, obtained from the PECS of a mouse 18 hours after vaccination with Violet-labeled cpsII 
parasites (e). Images of mCherry+veViolet+ve and mCherry+veViolet-ve cells isolated from the PECS 
of mice 18 hours post-administration of 106 DMSO-treated or 4-p-bpb-treated Violet-labeled, 
mCherry-expressing cpsII parasites (f). 
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Figure 3.2: The fate of cpsII parasites within infected host cells. RAW macrophages were 
infected with cpsII parasites and examined using immunofluorescence assays (a,b) or electron 
microscopy (c,d) to determine the fate and cellular localization of the parasites. CpsII-infected 
RAW IFN-γ (100 units/ml) and LPS (0.1 ng/ml) activated-macrophages were stained for GRA1 
(a protein secreted by T. gondii) to identify the parasitophorous vacuole followed by goat-anti 
mouse IgG Alexa Fluor 594 and rabbit polyclonal sera against Irgb6 followed by goat anti-rabbit 
IgG Alexa Fluor 488 (a). LAMP-1 was localized using rat monoclonal antibody 1D4B followed by 
goat anti-rat IgG Alexa Fluor 594 and the parasite vacuole was localized with rabbit polyclonal 
sera against GRA7 followed by goat-anti rabbit IgG Alexa fluor 488 (b) at 3 hours, 24 hours and 
48 hours post-infection. Scale bars =10um. Electron micrograph images of infected macrophages 
treated with IFN-γ (50 units/ml) and LPS (10 ng/ml) or untreated at 2 hours post infection (c). 
Parasites persist in intact vacuoles and do not display blebbing or disruption of the 
parasitophorous vacuole. Some cpsII parasites were found to exhibit non-productive cell division 
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in IFN-γ and LPS- treated or untreated macrophages when examined 24 hours post-infection 
(d). Scale bars = 1.5um. 
  
!
!
77 
 
 
Figure 3.3: Composition of total cell populations, mCherry+veViolet-ve cell populations, and 
mCherry+veViolet+ve populations from the PECS of total mice. Mice were vaccinated with 106 
Violet-labeled, mCherry-expressing cpsII parasites intraperitoneally and sacrificed 18 hours post-
vaccination. Cell type composition of total peritoneal cell populations in naïve and vaccinated 
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mice, and the cell type composition of mCherry+veViolet-ve cells and mCherry+veViolet+ve cells in 
vaccinated mice depicted as pie charts (left) and bar graphs (right) (a). Percentages of Total 
PECS in naïve mice, total PECS cells in vaccinated mice, and mCherry+veViolet+ve cells that are 
dendritic cells are depicted (b). T/B/NK cells are identified by expression of CD3,CD19, or NK1.1.  
Dendritic cells were identified as CD3-ve,CD19-ve,NK1.1-ve,CD11cHI,MHCIIHI.  Monocytes and 
neutrophils were defined as CD3-ve,CD19-ve,NK1.1-ve,CD11cLOW-INT,Gr-1+ve.  Macrophages were 
identified as CD3-ve,CD19-ve,NK1.1-ve,CD11cLOW-INT,Gr-1-ve,CD11bINTorHI.  *p<0.05;***p<0.0005.  
AVG±STDEV. A paired, two-tailed student’s t test was used to compare the percentages of 
infected cells that are dendritic cells with the percentages of cells that are dendritic cells in the 
total PECS of vaccinated mice. 
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Figure 3.4: Activation status of mCherry+veViolet-ve and mCherry+veViolet+ve macrophages 
and dendritic cells. Mice were administered parasites as described in Figure 3.3. At 18 hours 
post-vaccination, expression of the antigen presentation molecules MHCI (a) and MHCII (b) and 
expression of the costimulatory molecules CD86 (c) and CD40 (d) on CD11bHI macrophages and 
dendritic cells was determined by flow cytometry. Macrophages are identified as CD3-ve,CD19-
ve,NK1.1-ve,CD11c-ve,Gr-1-ve,CD11bHI cells. Dendritic cells are identified as CD3-ve,CD19-ve,NK1.1-
ve,CD11cHI,MCHIIHI. Confidence intervals were determined using the Bonferroni correction 
method.  *p<0.017;**p<0.0017;***p<0.00017. AVG±SE. Paired, two-tailed student’s t tests were 
used to compare expression levels of molecules on populations within cpsII-vaccinated mice. 
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Figure 3.5: Dendritic cells are required for optimal CD4+ and CD8+ T cell responses. CD11c-
DTR mice were administered diphtheria toxin 1 day prior to cpsII-OVA vaccination. At the time of 
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vaccination, some mice were sacrificed to determine the efficiency of depletion. Percentages and 
numbers of dendritic cells from the spleen are shown. FACS plots are gated on CD3-,CD19-
,NK1.1- cells (a). Eight days following vaccination, mice were sacrificed and total and tetramer-
specific CD4+ and CD8+ T cell responses were analyzed. Total CD4+ T cell responses from the 
spleens are shown (b, top). Tetramer-specific CD4+ T cell responses from pooled lymph nodes 
and splenocytes were determined in a separate experiment (b, bottom). Flow plots are gated on 
CD4+ T cells (b), and the population examined was magnetically enriched for the tetramer+ve 
population (bottom). Total and OVA-specific CD8+ T cell responses from the PECS are depicted 
(c), and flow plots are gated on CD8+ T cells. Significant differences in tetramer and total CD8+ T 
cell responses between WT and CD11c-DTR mice were also apparent in the spleen. *p<0.05; 
**p<0.005. AVG±SE. 
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Figure 3.6: Active invasion is required for adaptive immune responses to T. gondii. cpsII-
OVA parasites were heat-killed, treated with the invasion inhibitor 4-p-bpb or left untreated and 
administered to mice intraperitoneally. Tetramer-specific and total CD4+ (a) and CD8+ (b) T cell 
responses were measured from cells isolated from the spleen and lymph nodes (pooled) 10 days 
post-vaccination. Flow plots are gated on Foxp3-ve CD4+ T cells (a, top) or CD4+ T cells (a, 
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bottom) and the population examined at the bottom of A was enriched for tetramer+ve cells. Flow 
plots in B are gated on CD8+ T cells. *p<0.05; **p<0.005. AVG±SE.  
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Figure 3.7: Infected cells are sufficient to induce CD4+ and CD8+ T cell responses. 
Splenocytes were harvested from WT mice that were administered Flt3L-expressing tumors ~2 
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weeks prior, magnetically enriched for dendritic cells, and were incubated with Violet-labeled, 
mCherry-expressing cpsII-OVA parasites overnight. The following day, dendritic cells were sorted 
into mCherry+veViolet+ve (infected) and mCherry+veViolet-ve (uninfected) populations and 104 
dendritic cells from each population were administered to mice. 10 days later, mice were 
sacrificed and CD4+ (a) and CD8+ (b) T cell responses were analyzed. Pooled splenocytes and 
lymphocytes are shown. Populations shown depicting CD4+-tetramer binding are enriched for the 
tetramer+ve population (a, bottom). The data depicting tetramer-specific and total CD4+ T cell 
responses are from two separate experiments. Flow plots are gated on Foxp3-ve CD4+ T cells (a, 
top), CD4+ T cells (a, bottom) or CD8+ T cells (b). Parasite burdens from the PECS of mice 5 
days post-challenge with 103 tachyzoites of a highly virulent, replicating strain of T. gondii, 
administered 21 days following vaccination with 104 infected or uninfected dendritic cells, 
analyzed by flow cytometry (c).  *p<0.05; **p<0.005. AVG±SE.  
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Figure 3.S1: Images of mCherry+veViolet+ve bone marrow derived macrophages 18 hours 
following exposure to Violet-labeled, mCherry-expressing cpsII parasites. 
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Figure 3.S2: Images of mCherry+veViolet-ve bone marrow derived macrophages 18 hours 
following exposure to Violet-labeled, mCherry-expressing cpsII parasites. 
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Figure 3.S3: Images of mCherry+veViolet-ve bone marrow derived macrophages 18 hours 
following exposure to Violet-labeled, mCherry-expressing cpsII parasites, which were pre-treated 
with 4-p-bpb. 
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Figure 3.S4: Images of mCherry+veViolet+ve cells isolated from the PECS of mice 18 hours post-
infection with 106 Violet-labeled, mCherry-expressing cpsII parasites.  
 
!
!
90 
 
Figure 3.S5: Images of mCherry+veViolet-ve cells isolated from the PECS of mice 18 hours post-
infection with 106 Violet-labeled, mCherry-expressing cpsII parasites.  
  
B mCherry+Violet- (Utx)
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Figure 3S.6: Images of mCherry+veViolet-ve cells isolated from the PECS of mice 18 hours post-
administration of 4-p-bpb-treated, Violet-labeled, mCherry-expressing cpsII parasites.   
!
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Figure 3S.7: CD4+ and CD8+ T cell responses to cpsII-OVA vaccination in Flt3L KO mice. 
Flt3L KO mice were vaccinated with 105 cpsII-OVA parasites intraperitoneally and CD4+ and 
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CD8+ T cell responses from the spleen and lymph nodes (pooled) were examined at 10 days 
post-vaccination. CD4+ T cell responses are shown (a). Flow plots shown in A are gated on 
Foxp3-ve CD4+ T cells (top) or total CD4+ T cells (bottom), and the populations examined at the 
bottom of A were enriched for the tetramer+ve population. CD8+ T cell responses in the spleen and 
lymph nodes (pooled) were also examined (b). Flow plots shown in B are gated on CD8+ T cells. 
*p<0.05; **p<0.005.  ***p<0.0005. AVG±SE. 
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Figure 3.S8: CD4+ and CD8+ T cell responses in WT and Batf3 KO mice. WT or Batf3 KO 
mice were vaccinated with 105 cpsII-OVA parasites and examined 10 days post-vaccination. 
CD4+ T cell responses from the cells isolated from the spleen and lymph nodes (pooled) are 
shown (a). Flow plots in A are gated on Foxp3-veCD4+ T cells (top), or total CD4+ T cells (bottom) 
!
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and the populations examined in the bottom flow plots are enriched for the tetramer+ve population. 
CD8+ T cell responses from cells isolated from the spleen and lymph nodes (pooled) are also 
shown (b). Flow plots in B are gated on CD8+ T cells.   *P<0.05.  CD4+ and CD8+ T cell data 
shown are from two separate experiments. AVG±SE.   
!
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CHAPTER 4: DISCUSSION AND FUTURE DIRECTIONS 
Introduction 
Since their discovery forty years ago, it has become increasingly apparent that dendritic cells 
serve important roles in bridging the innate and adaptive immune responses (Steinman, 2012). 
The experiments performed in this thesis, as well as other findings published since these studies 
were commenced, have underscored the critical role that dendritic cells have in immunity to T. 
gondii. These experiments have also provided novel insight into the mechanisms by which 
dendritic cell populations are regulated during infection, as well as the specific mechanisms by 
which dendritic cells must interact with parasites in order to initiate CD4+ and CD8+ T cell 
responses.  In this chapter, the implications of these findings, their applications for human 
medicine, and future directions for this research will be discussed. 
 
Factors affecting dendritic cell populations during infection 
The studies in this thesis examining the role of Flt3L have provided several novel insights 
regarding the roles of dendritic cells and this cytokine in the immune response to T. gondii.  In 
addition to underscoring the important roles that dendritic cells play in immunity, they have also 
demonstrated that the infection-induced expansion of dendritic cell populations can occur 
independently of Flt3L. Recent studies have demonstrated that the inflammatory cytokines IL-12 
and IFN-! can induce expression of the transcription factors Batf and Batf2, which can promote 
development of CD8"+ dendritic cells in the absence of the transcription factor Batf3 (Tussiwand 
et al., 2012). It is also possible that the IL-12 and IFN-!-induced expression of these transcription 
factors contributes to the infection-induced expansion of CD8"+ dendritic cells in wild type mice 
described herein and described elsewhere (Mashayekhi et al., 2011). This hypothesis could be 
tested using bone marrow chimeras in which wild type mice are reconstituted with wild type bone 
marrow mixed with bone marrow deficient for the IL-12 receptor, the IFN-! receptor, Batf, or 
Batf2. The infection-induced increase in numbers of dendritic cells may also be partially 
accounted for by the conversion of inflammatory monocytes to dendritic cells.  Indeed, recent 
studies have demonstrated that adoptively transferred congenic inflammatory monocytes can 
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develop into dendritic cells in mice infected with T. gondii (Goldszmid et al., 2012). It is also 
important to note that while the studies described herein demonstrate that the expansion of 
dendritic cells can occur independently of Flt3L, this does not rule out the possibility that Flt3L 
may have a partial or redundant role in this process. Neutralizing Flt3L or the cytokine GM-CSF 
(which promotes the development of inflammatory monocytes into dendritic cells (Xu et al., 2007)) 
in wild type mice during infection with T. gondii may be effective strategies to dissect the role that 
these cytokines play during infection from their roles in dendritic cell homeostasis. 
 
The physiological implications of the inflammation-induced expansion of dendritic cells 
While the mechanisms by which the infection-induced expansion of dendritic cells occurs remain 
unclear, previous studies have provided insight into the potential physiological significance of this 
phenomenon. For example, studies comparing the CD8+ T cell responses during infection with 
the highly virulent RH strain of T. gondii with the CD8+ T cell responses induced by the less 
virulent Pru strain revealed that a greater expansion of dendritic cells during infection with Pru 
correlated with greater CD8+ T cell responses (Tait et al., 2010). Similarly, an infection-induced 
increase in numbers of dendritic cells during infection with Plasmodium resulted in greater CD8+ 
T cell responses (Guermonprez et al., 2013). In contrast to these reports, vaccination with the 
cpsII strain of T. gondii was found to induce CD8+ T cell responses of similar magnitude to the 
Pru strain, despite the fact that no expansion of dendritic cells was apparent following vaccination 
with cpsII (Jordan et al., 2009)(unpublished data).  One possible explanation for these findings is 
that dendritic cell expansion is critical for immunity in the context of infection, but not vaccination. 
Comparisons between infection with replicating and replication-deficient strains of T. gondii may 
provide a convenient system for interrogating the differential requirements for dendritic cell 
expansion, and identifying the factors that govern this expansion during toxoplasmosis will also 
be helpful in determining the physiological significance of this phenomenon. 
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Infection-induced expression of Flt3L 
Given that ligands for TLRs 3,4 and 9 can induce increased expression of Flt3L in vivo!
(Eidenschenk et al., 2010), and T. gondii can signal through TLR4!(Debierre-Grockiego et al., 
2007), it was somewhat surprising that expression of Flt3L was not increased following infection 
with T. gondii.  This finding also contrasts with work showing that increased expression of Flt3L is 
induced following infection with Plasmodium and Mouse Cytomegalovirus (Debierre-Grockiego et 
al., 2007; Guermonprez et al., 2013). Interestingly, the Plasmodium-induced expression of Flt3L 
was dependent upon Type I Interferon (IFN) responses (Guermonprez et al., 2013), and while 
much is known about the ability of T. gondii to drive production of IL-12 and IFN-!, relatively less 
is known regarding the role of Type I IFNs during toxoplasmosis, or the parasite’s ability to induce 
these responses (Lieberman and Hunter, 2002). Perhaps Type I IFN-induced expression of Flt3L 
and IL-12 driven expression of Batf and Batf2 (discussed in the previous section) are parallel 
pathways by which hosts can expand dendritic cell populations during different types of 
infections.   
 
Implications for human disease 
While the increased susceptibility of Flt3L KO mice to toxoplasmosis underscores the importance 
of Flt3L in immunity, identifying therapeutic applications for Flt3L is confounded by the pleiotropic 
properties of this cytokine. Thus, while Flt3L promotes optimal immune responses against 
infectious pathogens (Eidenschenk et al., 2010; Guermonprez et al., 2013), and has been used 
as an adjuvant to enhance responses to vaccination or immunotherapy (Kodama et al., 2010; 
Mwangi et al., 2011; Mwangi et al., 2002; Song et al., 2009; Yo et al., 2007; Zhou et al., 2010; 
Zurkova et al., 2009), treatment of mice with Flt3L can also result in increased numbers of 
regulatory T cells that inhibit auto-immune disease (Darrasse-Jeze et al., 2009). It may therefore 
be important to identify the variables that determine whether Flt3L promotes immune responses 
or inhibits them, in order to predict the effects of treating patients of various diseases with this 
cytokine. Given that toxoplasmosis is a disease that requires both an adequate Th1 immune 
response to control infection, and anti-inflammatory mechanisms to prevent severe 
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immunopathology (discussed in Chapter 1), murine infection with T. gondii may prove to be a 
useful model to further interrogate the roles of this cytokine. 
 
The role of infected cells in generating CD4+ and CD8+ T cell responses 
The studies in this thesis demonstrated that actively infected host cells, rather than cells that 
phagocytose T. gondii parasites, are potent inducers of CD4+ and CD8+ T cell responses. Several 
possible explanations may account for this. One possibility is that active invasion allows parasites 
to persist for longer periods than when they are phagocytosed and rapidly degraded, and this 
persistence of antigen is necessary to generate optimal immune responses. This idea stands in 
contrast to results obtained from studies using an attenuated strain of Listeria, in which T cell 
responses were similar regardless of the when the bacteria was cleared by treatment with 
antibiotics (Mercado et al., 2000). Another possibility is that the persistence of parasites results in 
greater quantities of antigen, since many antigens from T. gondii that are recognized by CD4+ 
and CD8+ T cells are secreted by the parasite (Blanchard et al., 2008; Frickel et al., 2008; Gregg 
et al., 2011; Kwok et al., 2003; Pepper et al., 2004).  However, CD8+ T cells specific for the 
protein Tgd_057, which is expressed in the cytoplasm of the parasite (Wilson et al., 2010), were 
also abrogated when invasion was blocked, suggesting that increased amounts of secreted 
antigen can not solely account for the critical role for invasion to generate CD4+ and CD8+ T cell 
responses. 
 Another possible explanation for the failure of phagocytosed parasites to induce CD4+ or 
CD8+ T cell responses is that this pathway may provide insufficient levels of inflammatory signals, 
and the failure of cells that have phagocytosed T. gondii to upregulate the co-stimulatory 
molecule CD86 is consistent with this idea. Inflammatory stimuli can be required to promote 
phagosomal maturation and antigen processing (Blander, 2008; Blander and Medzhitov, 2006), 
or to induce the expression of cytokines and co-stimulatory signals necessary for T cell activation 
(Chen and Flies, 2013; Joffre et al., 2009), and several factors may account for the ability of live 
(as opposed to phagocytosed) parasites to uniquely activate innate sensing mechanisms. Since 
some antigens from T. gondii that are sensed by innate immune receptors may be secreted (such 
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as profilin (Pifer et al., 2011)), the increased persistence of parasites that occurs when they are 
able to invade host cells may result in greater amounts of inflammatory stimuli. The distribution of 
innate immune receptors within host cells also may result in the activation of unique pathways, 
depending on whether parasites are phagocytosed or actively invade (Iwasaki and Medzhitov, 
2010). Lastly, metabolic products from live parasites may activate sensing mechanisms that are 
not stimulated by dead (and thus non-metabolically active) parasites. The specific host factors 
that may be involved in the sensing of cpsII parasites are discussed in greater length in a later 
section of this chapter.  
 
Pathways that may lead to antigen presentation following cpsII vaccination 
Regardless of the underlying cause of the requirement for active invasion to generate T cell 
responses, this requirement suggests that either infected cells directly present antigen to T cells, 
or that infected cells are phagocytosed by cells (a process referred to as efferocytosis), and the 
efferocytosing-cell then primes naive T cells (Figure 4.1). Previous studies have been interpreted 
to support the idea that infected cells directly prime naïve T cells (Dzierszinski et al., 2007; 
Goldszmid et al., 2009; Gubbels et al., 2005), however it must be remembered that some of these 
studies did not distinguish active invasion from phagocytosis with the same granularity as the 
studies performed in this thesis, and many of the past studies utilized in vitro systems, which may 
not reflect what occurs in vivo. In vivo imaging studies have observed dendritic cells that do not 
contain intact parasites to interact extensively with antigen-specific T cells, suggesting that 
uninfected cells prime T cells (John et al., 2009)!(Chtanova et al., 2009). Consistent with the idea 
that antigen is acquired through the phagocytosis of infected cells (i.e. efferocytosis), previous 
studies have demonstrated that antigens derived from transferred murine dendritic cells can be 
expressed in the context of MHC molecules on the dendritic cell population of recipient mice 
(Inaba et al., 1998), and expression of MHCII is required from recipient mice for optimal CD4+ T 
cell responses following the transfer of peptide-pulsed dendritic cells!(Kleindienst and Brocker, 
2003). In the following sections, the implications of these two models are discussed. 
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Implications of the direct presentation of antigen by cpsII-infected cells to prime naïve T cells 
One surprising aspect of the model that infected cells directly prime CD4+ and CD8+ T cell 
responses is that the parental strain of the cpsII parasites (the RH strain) is known to induce an 
alternatively-activated phenotype in the cells that in infects, characterized by expression of the 
enzyme arginase-1, and reduced expression of IL-12 (Butcher et al., 2011; Saeij et al., 2007).  
Unlike classically activated macrophages, alternatively activated macrophages promote immune 
responses to allergens and helminthes, participate in anti-inflammatory responses, and are 
thought to be poor inducers of Th1 immune responses (Varin and Gordon, 2009). While the 
studies described in this thesis demonstrated that the infected cells were activated, they did not 
distinguish classical activation from alternative activation. Further experimentation will be required 
to determine whether cpsII parasites, like RH parasites, induce alternative activation, and to 
identify the sources of IL-12 that drive the CD8+ T cell response following vaccination with cpsII 
parasites. The dual-fluorescence reporter system developed in this thesis, used in combination 
with intracellular cytokine staining or fluorescent reporter systems to measure IL-12 production 
(Reinhardt et al., 2006),  may help to answer this question. 
 
Implications of efferocytosis as a means of acquiring antigen for presentation following cpsII 
vaccination 
The hypothesis that infected cells are phagocytosed implies a mechanisms by which these cells 
can be identified as targets for efferocytosis. In current models, cells are identified as targets for 
phagocytosis when they undergo apoptosis, and express phosphatidylserine on their surface, 
which ligates receptors on the surface of the efferocytosing-cell. This suggests the possibility of 
an innate sensing mechanism by which infected cells induce their own cell death in order to 
become targets for efferocytosis, and studies using bacterial models of infection have provided 
precedence for infection-induced apoptosis (Philip and Brodsky, 2012) as well as the 
efferocytosis of infected cells (Martin et al., 2012). However, many studies have observed T. 
gondii to have anti-apoptotic effects on infected cells (Laliberte and Carruthers, 2008). Perhaps 
these anti-apoptotic effects are impaired in cpsII parasites, as a result of their Uracil auxotrophy. 
!
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Alternatively, a direct sensing mechanism and infection-induced apoptosis may be unnecessary 
for efferocytosis to occur, as the relatively short half life of dendritic cells in vivo (Liu and 
Nussenzweig, 2010) may cause a sufficient number to be efferocytosed regardless of their 
infection status.  
 Another implication of the efferocytosis model is that the efferocytosing-cell must present 
the antigens it phagocytoses to naïve T cells that develop into effector cells, however this idea 
stands in contrast to current models that have emphasized the role of efferocytosis in inducing 
tolerogenic T cell responses (Steinman et al., 2003). Thus, if the efferocytosis model is correct, 
there is likely a sensing mechanism that leads the efferocytosing-cell to provide stimuli that 
promote Th1, rather than tolerogenic T cell responses. Such a sensing mechanism could 
conceivably result from the direct ligation of innate immune receptors in the efferocytosing-cell by 
foreign antigen, or from inflammatory mediators released by the infected cell that act upon the 
efferocytosing-cell (Figure 4.2). Regardless, determining the fate of infected cells in vivo will help 
to determine if antigen is in fact acquired through efferocytosis, and experiments to interrogate 
the relative contributions of efferocytosis and direct priming by infected cells are discussed in the 
following section. 
 
Future applications of the adoptive transfer of cpsII-infected dendritic cells 
The adoptive transfer system described in this thesis may be useful to determine the fate of 
infected cells, and this information could help to determine whether antigen is acquired through 
efferocytosis. Thus, infected congenic cells could be adoptively transferred to mice, and 
monitored over time to determine if they clear parasites, persist for long periods of time, or 
migrate to other locations. The dual-fluorescence system utilized in this thesis to distinguish 
active invasion from phagocytosis could easily be modified to detect efferocytosis in vivo, by 
engineering cells that express mCherry, infecting them with parasites, and labeling the infected 
cells with CellTraceTM Violet. This system could also be used to characterize the cells responsible 
for efferocytosis. Monitoring the interactions between infected cells and naïve T cells, or potential 
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efferocytosing-cells by two-photon microscopy may also provide insights into the mechanisms by 
which antigen is acquired for presentation. 
 The adoptive transfer of infected dendritic cells also provides a convenient system to 
distinguish the factors that are required from infected cells to generate CD4+ and CD8+ T cell 
responses from those that are required from uninfected cells. For example, while IL-12 has been 
implicated in promoting CD8+ T cell responses following cpsII vaccination (Wilson et al., 2010; 
Wilson and Hunter, 2008), it is currently unclear which cells (infected, or uninfected) are critical 
sources of this cytokine.  The role of infected cells as sources of IL-12 could be directly tested by 
transferring pre-infected IL-12p40-deficient cells to wild type mice, and comparing the resulting 
CD4+ and CD8+ T cell responses to those induced by the transfer of pre-infected wild type 
dendritic cells. Similarly, the roles of infected cells in direct presentation of antigen could be 
interrogated by transferring dendritic cells deficient in MHCI or MHCII, and comparing the 
resulting CD4+ and CD8+ T cell responses to those induced by the transfer of wild type dendritic 
cells. Manipulating dendritic cells prior to transfer could also be useful to test whether their 
efferocytosis leads to antigen presentation. Thus, transferred pre-infected dendritic cells could be 
treated with inhibitors of apoptosis, agents that promote apoptosis, factors that block efferocytic 
uptake (such as Annexin V, which binds phosphatidylserine (Fadok et al., 1998)) or factors that 
promote efferocytosis (such as anti-CD47 blocking antibodies or opsonizing antibodies for mouse 
cells (Gardai et al., 2006)) to determine the role that efferocytosis has in generating CD4+ and 
CD8+ T cell responses.   
 
The use of mCherry to study intracellular trafficking 
Regardless of whether antigen is directly presented by infected cells or presented by cells that 
phagocytose infected cells, the intracellular pathways by which phagocytosed antigens are 
processed and ultimately expressed on the surface of host cells remain to be determined.  The 
ability of mCherry fluorescence to persist long after parasites have been degraded may enable 
the intracellular trafficking pathways by which phagocytosed antigens are processed to be 
tracked.  Phagocytosed mCherry-expressing parasites may therefore be useful to determine how 
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T. gondii antigen is ultimately presented, and why cells that phagocytose free parasites fail to 
present antigen.  This technique may be broadly applicable to studying antigen presentation and 
intracellular trafficking pathways in a variety of systems, provided that the targets for 
phagocytosis can be labeled with mCherry. Combining this technique with other methods to 
fluorescently label intracellular structures (such as the use of LysoTracker® to identify acidified 
organelles or the use of cells expressing GFP-labeled MHCII molecules (Haller et al., 1996)!
(Chow et al., 2002)) may prove to be valuable in examining intracellular trafficking pathways.  
Such studies may provide clarity into the mechanisms by which phagocytosed antigens are 
cross-presented, which is currently an area of active research (Dresch et al., 2012; Joffre et al., 
2012; Lin et al., 2008).  
 
Innate sensing of Toxoplasma gondii 
While many reports have examined the roles of TLRs in immunity to T. gondii (Miller et al., 2009) 
(Denkers, 2010; Egan et al., 2009b; Pifer and Yarovinsky, 2011), fewer studies have examined 
the roles of TLR-independent mechanisms of sensing T. gondii, and there are several reasons to 
think these pathways are important. Firstly, the signaling molecule MyD88, which is required to 
mediate downstream signaling pathways from most TLRs, is not necessary for the generation of 
cpsII-induced immunity to T. gondii (Sukhumavasi et al., 2008). Secondly, a report published 
since the time these studies commenced observed the upregulation of CD86 in infected cells to 
occur independently of MyD88 (Morgado et al., 2011). Additionally, the unique phenotypes of 
cells that have phagocytosed T. gondii from those that are infected by the parasite point toward 
distinct sensing mechanisms for phagocytosed parasites, and those that actively invade host 
cells. Whereas TLRs are generally thought to sense phagocytosed antigens, the sensing of 
foreign pathogens within infected host cells is thought to be mediated by cytosolic receptors (such 
as the Nod-like receptors) (Iwasaki and Medzhitov, 2010). Collectively, these data point toward a 
role for TLR-independent mechanisms in sensing T. gondii and initiating adaptive immune 
responses. These results stand in contrast to current models that emphasize the roles of TLR-
stimulation in promoting antigen presentation (Blander, 2008). Identifying the innate mechanisms 
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that lead to the sensing of cpsII parasites and the presentation of parasite antigens following 
vaccination may therefore allow these pathways to serve as targets for vaccine design.  
 
Limitations of the cpsII model 
While  cpsII parasites have proven to be a useful tool to understand the host immune response to 
T. gondii, care must be taken in extrapolating the findings from these studies to a natural infection 
characterized by parasite replication, lysis of infected cells and overt inflammation. Inflammation 
can promote cross presentation (Dresch et al., 2012) and it is possible that other pathways of 
antigen presentation are engaged in this setting. However, IFN-! has microbiostatic effects on T. 
gondii (Langermans et al., 1992), which may recapitulate the pathways seen following cpsII 
vaccination during infection with replicating parasites. Regardless, the principles learned from 
studying systems in which overt inflammation is absent may be more applicable to the design of 
vaccines, which ideally should not induce as much inflammation as acute infection. 
 
Phagocytosis of T. gondii parasites in vivo 
The finding that parasites can be phagocytosed following infection raises the question of how the 
phagocytosis of parasites occurs in vivo. T. gondii-specific and non specific antibodies, as well as 
complement have been implicated in the opsonization of T. gondii for phagocytosis (Johnson et 
al., 1996) (Hammouda et al., 1995a; Schreiber and Feldman, 1980; Suzuki and Tsunematsu, 
1971; Vercammen et al., 1999). Furthermore, antibody-mediated opsonization may be critical for 
immunity to T. gondii, as mice deficient in B cells are susceptible to toxoplasmosis, and the 
passive transfer of anti-T. gondii antibodies can confer protection!(Kang et al., 2000).  The use of 
dual fluorescent reporters with varying pH sensitivity, and pharmacological inhibitors may be a 
useful system to address the roles of various factors in promoting phagocytosis in vivo. In 
addition to providing insight regarding the roles of these factors in immunity to T. gondii, the dual 
florescent reporter system may aid in testing the role of phagocytosis in immunity to other 
pathogens, or in determining the fate of various therapeutic agents in vivo.   
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Acidification of dendritic cell phagosomes 
One implication of the loss of violet fluorescence observed when dendritic cells phagocytose 
Violet-labeled, mCherry expressing parasites is that dendritic cell phagosomes acidify when 
parasites are phagocytosed. While some studies have observed the phagosomes of dendritic 
cells to acidify (reaching pH values as low as 4.5)  (Bettiol et al., 2010; Erwig et al., 2006; Thiele 
et al., 2003; Trombetta et al., 2003), other studies have observed dendritic cell phagosomes 
maintain a pH of ~7.5 following phagocytosis (Mantegazza et al., 2012; Savina et al., 2006). This 
apparent discrepancy may result from kinetic changes in the phagosomal pH over time, as the 
studies performed in this thesis examined 18 hours after exposure to parasites, and the more 
neutral pH has been observed within three hours of phagocytosis. Another potential explanation 
is that phagosomal maturation is governed by inflammatory signals, and the inflammatory signals 
provided by T. gondii differ than those provided by latex beads or LPS treatment of cells. Indeed, 
TLR signaling can increase rates of phagocytosis and phagosomal maturation in macrophages 
(Blander, 2008), and T. gondii has been reported to signal through TLRs 2,4,11 and 12 (Debierre-
Grockiego et al., 2007; Koblansky et al., 2013; Yarovinsky et al., 2005). The use of invasion-
blocked parasites and the mCherry/CellTraceTM Violet dual fluorescence system may therefore be 
a useful tool to answer questions regarding phagosomal maturation in a more physiological 
setting than occurs when latex beads are phagocytosed. Insights gained using such a system 
may prove useful for the optimization and design of vaccines or therapeutics that target the 
phagocytic pathway. 
 
Towards therapeutic applications of cpsII parasites  
Several aspects of the cpsII strain suggest the potential of replication-deficient T. gondii parasites 
to be used as a vaccine for toxoplasmosis, or as a vector for the delivery of immunotherapeutic 
antigens or antigens for vaccination against other pathogens. These qualities include the ability of 
the cpsII strain to induce long-lived CD4+ and CD8+ T cell responses, as well as its ability to 
preferentially invade dendritic cells. Additionally, these parasites can be easily cultured in the 
laboratory setting, unlike many other pathogens. In support of this idea, another attenuated strain 
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of T. gondii (the Ts-4 strain) has been used as a vector for vaccination against Plasmodium yoelii, 
and conferred partial protection from challenge with this pathogen (Charest et al., 2000). 
However, the cpsII strain has been observed to occasionally revert to its wild-type phenotype, 
resulting in the death of vaccinated mice (data not shown), and therefore is not sufficiently safe 
for therapeutic use in humans. Furthermore, while cpsII vaccination can induce memory 
responses that protect against challenge with T. gondii, protection against challenge with other 
pathogens may require quantitatively or qualitatively different T cell responses. For example, full 
protection against Plasmodium may require extremely large pools of memory T cells (Schmidt et 
al., 2010), which are much larger than those induced by cpsII vaccination. Further genetic 
manipulation of the parasite may therefore be necessary to make attenuated T. gondii sufficiently 
safe for use in humans, and to optimize the memory responses induced by this parasite if it is to 
be used as a vector for other pathogens. Indeed, efforts to engineer safer non-replicating 
parasites are already underway (Fox and Bzik, 2010), and genetic screens have identified 
numerous genes associated with virulence in T. gondii (Saeij et al., 2006; Taylor et al., 2006).  In 
the following sections, the contributions of two virulence factors, ROP18 and ROP16 are 
discussed. 
 
ROP 18 
One recently identified virulence factor that merits special attention is the secreted kinase 
ROP18, which provides a major contribution to the virulence of T. gondii during murine infection 
(Saeij et al., 2006; Taylor et al., 2006). As described in the introduction of this thesis, ROP18 
directly phosphorylates members of the IRG enzyme family, and thereby prevents the disruption 
of the parasitophorous vacuole (Fentress et al., 2010; Fentress and Sibley, 2011; Steinfeldt et al., 
2010). Although there is evidence that this enzyme is less important for evading immunity when 
human cells are infected (Niedelman et al., 2012), there may be functional orthologous of ROP18 
specialized to phosphorylate immune enzymes in human cells. Deletion of ROP18 or functional 
orthologes that mediate virulence during human toxoplasmosis may therefore be one strategy to 
make administering cpsII parasites to humans safer. Additionally, ROP18 has been proposed to 
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inhibit CD8+ T cell responses by binding to the host protein ATF6-#, and deleting ROP18 from 
cpsII parasites may therefore enhance their efficacy (Yamamoto and Takeda, 2012). However, 
the role of parasite persistence in generating T cell responses and memory following cpsII 
vaccination is not currently known, and deleting ROP18 could therefore have adverse effects on 
the efficacy of cpsII parasites as a vaccine. Interrogating how ROP18 and members of the IRG 
family affect cpsII-induced T cell responses could provide insight into the roles of parasite 
persistence and vacuolar disruption in generating T cell responses, and therefore facilitate the 
design of future vaccines. 
 
ROP16 
Another virulence factor that may affect the generation of adaptive immune responses is the 
secreted kinase ROP16, which phosphorylates the signaling molecules STAT3 and STAT6, thus 
promoting the development of alternatively activated host cells (described earlier in this section) 
which may inhibit the generation of Th1 immune responses (Butcher et al., 2011; Saeij et al., 
2007). While the deletion of this gene could potentially result in greater CD4+ and CD8+ T cell 
responses, anti-inflammatory cytokines such as IL-10 can also promote memory formation (Cui et 
al., 2011), and alternatively activated cells can act as a source of this cytokine (Weisser et al., 
2013). Further experimentation is required to determine how ROP16 affects both innate cells 
infected by the parasite, as well as the generation of adaptive immune responses. 
 
Designing attenuated pathogens for vaccination  
While cpsII parasites may function as a vector for antigen delivery, it may be a more effective 
strategy to generate other attenuated pathogens for vaccination purposes. While the ability of 
cpsII parasites to induce long-lived protection demonstrates that deleting genes necessary for 
replication can be an effective strategy for developing other live attenuated vaccines, this strategy 
may not work for other pathogens. Given the genetic malleability of T. gondii, and the ability of the 
cpsII parasites to induce immune responses while controlling for antigenic burden, vaccination 
with cpsII may serve as a convenient system to determine how the deletion of other types of 
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genes (eg. metabolic genes, structural genes, virulence factors) affects adaptive immune 
responses. The principles learned from such studies may than be applied to develop live 
attenuated vaccines for other, less genetically malleable pathogens.   
 
Targeting antigen for T cell responses 
The design of effective vaccines that elicit protective CD8+ T cell responses has been a long-
standing and elusive goal in the field of vaccinology. If the use of live attenuated T. gondii proves 
to be insufficiently safe for human use, perhaps the properties of cpsII parasites that promote the 
generation of protective T cell responses can be identified and mimicked using other vaccination 
systems. The finding that phagocytosis of antigen is insufficient to generate T cell responses 
highlights the need for other mechanisms of antigen delivery.  Cytoplasmic delivery of antigen 
using nanoparticles has been developed and tested in murine models, where it has been an 
effective strategy for generating T cell responses (Moon et al., 2012). If efferocytosis is found to 
be the pathway by which antigen is acquired for presentation following cpsII vaccination, perhaps 
targeting antigens or antigen-bearing nanoparticles to the efferocytic pathway would be an 
effective strategy for generating T cell responses. Identifying the innate sensing mechanisms that 
may determine whether a cell that efferocytoses foreign antigens induces tolerant or protective T 
cells may also be useful for vaccine design.  
 
Generating effective T cell memory 
Although the focus of this thesis has been on the factors that lead to the generation of CD4+ and 
CD8+ T cell responses, the generation of protective immunity also requires that long-lived 
memory cells be maintained following vaccination. Current models suggest memory formation is 
inhibited by inflammatory signals and antigen persistence (Cui and Kaech, 2010; Kaech and 
Wherry, 2007)!(Joshi et al., 2007; Sarkar et al., 2008), however inflammatory signals are also 
required to drive T cell responses (Curtsinger and Mescher, 2010). Since the cpsII parasites are 
able to induce sufficient inflammation to generate T cell responses and the formation of memory 
cells, while avoiding the overt inflammation characteristic of actual infection, they are an ideal 
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model to study the specific sources of inflammatory stimuli necessary to generate long-lived T cell 
memory. While IL-12 has been shown to promote the T cell responses induced by cpsII 
vaccination (Wilson et al., 2010; Wilson et al., 2008), the sources of this IL-12 and the 
inflammatory stimuli that elicit its expression remain unknown. Identifying the cellular sources of 
IL-12 critical for the induction of T cell responses following cpsII vaccination may allow for the 
design of targeted adjuvants that optimize the development of T cell memory. 
 Although memory T cells are often understood as T cells that persist in the absence of 
their cognate antigen (Cui and Kaech, 2010), and persistence of antigen can inhibit the 
development of memory cells, several studies have demonstrated that persistence of antigen is 
necessary for optimal protection upon re-encountering a pathogen (Belkaid et al., 2002; Cockburn 
et al., 2010).  Although studies in this thesis and other reports have suggested that viable cpsII 
parasites are cleared following infection (Jordan et al., 2009), it remains to be determined 
whether antigen depots persist following cpsII vaccination. Adoptively transferring CFSE-labeled 
congenic antigen-specific CD8+ T cells to cpsII-vaccinated mice at various times following 
vaccination, and measuring their proliferation may be useful to determine whether antigen 
persists following cpsII vaccination (Cockburn et al., 2010).  
 Another interesting characteristic of the cpsII-vaccine system is that the CD8+ T cells 
induced by vaccination retain an effector phenotype (characterized by high expression of KLRG1 
and low expression of CD62L and the IL-7R) long after vaccination (Jordan et al., 2009).  Current 
paradigms maintain that during acute infection, CD8+ T cells can be characterized as either 
short-lived effector cells (which express high levels of KLRG1 and low levels of IL-7R) and 
memory-precursor effector cells (which express low levels of KLRG1 and high levels of the IL-
7R), and memory precursor cells display greater homeostatic turnover, longer half lives, and 
greater potential to expand upon reinfection (Cui et al., 2011; Joshi et al., 2007; Sarkar et al., 
2008).  Although memory CD8+ T cells that persist following cpsII vaccination gradually shift to a 
KLRG1LOWIL-7RHI phenotype, this transition occurs very slowly in contrast to other systems. This 
is surprising, given that inflammation is thought to promote the development of KLRG1HIIL-7RLOW 
cells, and cpsII vaccination induces relatively low levels of inflammation. Murine vaccination with 
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cpsII parasites may therefore be a useful model to identify other factors that regulate the 
development of short-lived effector cells, and the factors that regulate the transition of the 
memory pool toward a KLRG1LOW-IL-7RHI phenotype. 
  It is also worth noting that although central memory T cells (CD62LHIIL-7RHIKLRG1LOW) 
are thought to confer greater protection than effector cells (CD62LLOWIL-7RLOWKLRG1HI) (Wherry 
and Ahmed, 2004; Wherry et al., 2003), the protection conferred by cpsII vaccination correlates 
with large pools of effector cell CD8+ T cells. Furthermore, although neutralizing IL-12 at the time 
of vaccination can result in greater expansion of CD8+ T cells at the time of challenge (Wilson et 
al., 2010), the effect that this expansion has on parasite clearance following challenge is unclear, 
especially given that cpsII vaccination of IL-12-deficient mice fails to confer protection 
(Sukhumavasi et al., 2008).  Sorting on KLRG1HI and KLRG1LOW CD8+ T cells from vaccinated 
mice and transferring these cells to recipients that are subsequently challenged with virulent T. 
gondii may be useful to determine which population is responsible for parasite clearance. 
Additionally, the effects of neutralizing IL-12 during vaccination on the ability of CD8+ T cells to 
clear the parasite at the time of rechallenge should be examined. It may indeed be that during 
infection with T. gondii long-lived effector cells provide greater protection than central memory T 
cells. Such a finding would have broad impact in the filed of vaccinology, as it would suggest that 
the ideal phenotype of memory T cells to confer optimal protection may differ among infections 
with various pathogens. 
 
Conclusions 
The lack of effective vaccines that elicit long-lived memory T cells underscores the need to better 
understand the factors that contribute to the induction of adaptive immune responses.  The 
findings presented in this thesis highlight the prominent role of dendritic cells in the development 
of protective immunity to T. gondii and begin to identify the specific cell populations, and specific 
interactions between host cells and the parasite, that are required for adaptive immune responses 
to occur. The studies using mice deficient in the cytokine Flt3L establish Flt3L knockout mice as a 
useful tool to study the role of dendritic cells during immunity to T. gondii, and demonstrate that 
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while Flt3L is not necessary for the infection-induced expansion of dendritic cells that occurs 
following infection, or the generation of adaptive immune responses during toxoplasmosis, it is 
required for sufficient production of IL-12 to protect against this pathogen.  The discovery that 
active invasion is required to generate T cell responses may help to explain why live attenuated 
vaccines are often an effective strategy, and this finding may facilitate the design of vaccination 
strategies that mimic live attenuated vaccines but mitigate the potential health hazards associated 
with them. The use of the dual fluorescent reporter system described herein should also be 
broadly applicable to tracking the fate of other intracellular pathogens, and may aid in determining 
how phagocytosed antigens are processed, trafficked and ultimately presented. Future studies 
should aim to determine whether infected cells can directly prime naïve T cells, what role 
efferocytosis has in the induction of protective immunity to T. gondii, and further identify the 
innate sensing mechanisms and inflammatory signals that are ultimately responsible for the 
development of adaptive immune responses to this pathogen. 
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Figure 4.1:  Hypothetical pathways of antigen presentation following active invasion.  
Infected cells may directly present antigen to T cells (A) or may by efferocytosed, leading to 
antigen presentation by a secondary cell.  
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Figure 4.2:  Potential mechanisms of sensing foreign antigens in the context of 
efferocytosis.  The infected, apoptotic cell may release inflammatory signals that are sensed by 
the efferocytosing-cell, or the efferoyctosing-cell may directly recognize the Pathogen-Associated-
Molecular-Patterns (PAMS) from T. gondii after the breakdown of the cell that is efferocytosed 
(and the parasite inside of it). 
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